1. A legislative framework of France
1.1.A List of illicit drugs
See the full list in Annex 1
• Cannabis is today the most consumed illegal drug in the country. In the following graph, we can see the evolution of cannabis consumption levels between 1992 and 2021, amongst people aged from 18 to 64 (in %)
• Cocaine, MDMA/Ecstasy, Mushrooms, Amphetamines and Heroin are the most popular drugs after cannabis. See belox, the evolution of consumption over the years (between 1992 and 2017) amongst people aged from 18 to 64 (in %).
Drug use is regularly measured by various organizations, such as Public Health France (SPF) or the French Observatory on Drugs and Addiction Trends (OFDT). The latter also produces analyzes on these uses with the aim of “enlightening public authorities, professionals in the field and the general public about the phenomenon of drugs and addictions”, says service-public.fr. 22 Illegal drugs can be found in "fours", where at first you will buy in person and then you can place orders via social media using the QR code that will be on the drug's packaging. Or if a friend or family member has ordered before, you can ask for their contact to place orders.
1.2. Price of most common illicit drugs
figure 1: Magic Mushroom prices ( sources telegram)
figure 2: Magic Mushroom hash prices ( sources telegram)
figure 3: Magic Mushroom xanax prices ( sources telegram)
figure 4: Magic Mushroom Cocaine prices ( sources telegram)
figure 5: Magic Mushroom Ecstasy prices ( sources telegram)
1.3. Principles by which are determined the status of the substances
In France, the National Agency for the Safety of Medicines and Health Products (ANSM) is one of the main agencies responsible for conducting scientific assessments of the risks associated with drugs and medications. These assessments cover various aspects, including the effects on physical and mental health, the risks of dependence, side effects, and drug interactions. The conclusions of these assessments are often used to inform regulatory decisions regarding the classification and regulation of substances. However, it should be noted that ANSM is not the only agency or mechanism involved in determining the status of substances in France.
In addition to assessments conducted by ANSM and other similar organizations, several other mechanisms can be used to determine the status of substances in France. This may include political, economic, and social considerations, as well as pressure from consumer rights groups or special interest groups. Furthermore, recommendations and decisions from international organizations, such as the World Health Organization (WHO) for globally controlled substances, can also influence substance classification. Centers for Evaluation and Information on Pharmacodependence-Addictovigilance (CEIP-A) also play a crucial role in assessing the risks and monitoring the use of addictive substances in France.
1.4 List of legal drugs
• Alcohol
• Tobacco
• Painkillers
• Sleeping pills
• Glues
• Solvents
These are the most popular drugs in France that you can buy legally in stores such as supermarkets, tobacconists, pharmacies and other everyday stores. Despite being legal, there are laws and regulations in force in France that restrict the consumption or purchase of certain legal drugs on specific days, times and quantities.
For example, alcohol sales are prohibited between 22:00 and 08:00 and at gas stations between 18:00 and 08:00, in accordance with local regulations intended to reduce excessive drinking and public disturbances.
1.5 Lists of controlled chemicals (drug precursors)
See full list in Annex 2
CATEGORY 1
CATEGORY 2-A
CATEGORY 2-B
CATEGORY 3
List of countries appearing in Annex IV, point II of Regulation (EC) No.225/2011
amending Regulation (EC) No. 1277/2005 of the Commission of July 27, 2005
CATEGORY 4
1.6 The penalties for advertising online stores, selling illegal drugs
France's legislative framework regarding the trade and consumption of drugs is strict and encompasses a wide range of substances. French law divides drugs into different categories based on their potential for abuse and impact on public health. Laws regarding the trade and consumption of drugs in France are mainly governed by the Penal Code, the Public Health Code, and specific legislations on controlled substances. The illicit transfer or offering of drugs to a person for personal consumption is punishable by a prison sentence of five years and a fine of 75.000 euros. But prison sentences ranging from several years to decades, depending on the severity of the crime, the amount and type of drugs involved, as well as the specific circumstances of the case and the individual convicted, may face additional legal restrictions, such as a prohibition on consumption in certain commercial activities, access to certain technologies or even life imprisonment and a fine of up to 7,500,000 euros in more serious cases. Drugs are classified into different categories such as narcotics, psychotropic substances, and products under special control. The possession, sale, and trafficking of illegal drugs are punishable by law, with penalties ranging from heavy fines to imprisonment, depending on the quantity and nature of the drug involved. France also adopts a zero-tolerance approach regarding drug trafficking, especially concerning narcotics such as heroin and cocaine. Additionally, France has implemented measures to prevent drug consumption, including education and prevention programs, treatment for drug addicts, and the application of alternative penalties for non-violent users, such as participation in rehabilitation programs. 4 However, despite the strict enforcement of anti-drug laws, France faces persistent challenges related to drug trafficking and consumption, especially in densely populated urban areas. In relation to the consumer, whether of cannabis, ecstasy, cocaine or any other illicit psychoactive substance, consumption constitutes a crime punishable by a maximum sentence of 1 year in prison and a fine of €3,750. Since 2019, under article L.3421-1 of the public health code, the illicit use of narcotics can give rise to a fixed fine. Thus, a person arrested for drug use or possession of small quantities can receive a fixed fine of 200 euros issued immediately by the police, payment of this fine puts an end to any legal proceedings.
- Directing or organizing a group with the aim of producing, manufacturing, importing, exporting, transporting, holding, offering, transferring, acquiring, or illicitly using narcotics is punishable by life imprisonment and a fine of 7,500,000 euros. (Article 222-34 of the Penal Code)
- Illicit production or manufacturing of narcotics is punishable by 20 years of life imprisonment and a fine of 7,500,000 euros. These offenses are punishable by 30 years of life imprisonment and a fine of 7,500,000 euros when committed by an organized group. (Article 222-35 of the Penal Code)
- Illicit import or export of narcotics is punishable by 10 years of imprisonment and a fine of 7,500,000 euros. These offenses are punishable by 30 years of life imprisonment and a fine of 7,500,000 euros when committed by an organized group. (Article 222-36 of the Penal Code)
- Illicit transportation, possession, offering, transferring, acquiring, or use of narcotics is punishable by 10 years of imprisonment and a fine of 7,500,000 euros. (Article 222-37 of the Penal Code)
- Illicit offering or transferring of narcotics to an individual for personal consumption is punishable by 5 years of imprisonment and a fine of 75,000 euros. This penalty is increased to 10 years when narcotics are offered or transferred to minors. (Article 222-39 of the Penal Code)
- Money laundering of the proceeds from narcotics trafficking is punishable by 10 years of imprisonment and a fine of 750,000 euros. (Article 222-38 of the Penal Code)
2 A characterization of the drug business in France
2.1 A list compilation of local online sellers and traffic on their websites
Some of the most popular sites in France to buy from are:
Telegram : NiceWeedMarket ( 636 followers ) , Jaune mousseux Frenchweed ( 2K3 followers ), uberweed31 ( 676 followers )
Snapchat : Caliweed coffee 420, anna_emily411, weedhash4200, pablo_weed33 , goodl20233099
Whatsapp : +33 6 05 80 49 73
Darknet: Cocorico Market ( but he is down, exitscam from the owner )
Zamnesia: https://www.zamnesia.fr/
Philosopher Seeds: https://www.philosopherseeds.com/fr/
Shayana Shop: https://french.shayanashop.com/
Royal Queen Seeds: https://www.royalqueenseeds.fr/
2.2 Popular marketplaces in France and analysis of their sites/traffic
Darknet : Cocorico Market ( but he is down, exitscam from the owner, in the last update)
Telegram : Jaune mousseux Frenchweed ( 2.3K followers )
FrenchWeedChemsnotesplug ( 421 followers)
LA FRAPPE A YODA ( 3.9K followers)
Dzmafia ( 2633 followers )
Mistral38 Lyon (1.4K)
After small drug dealers increase their demand, they join forces with groups of traffickers who establish a small region as their area of activity and define a place for users to buy drugs in person in places known as “Fours” or ovens in English, thus increasing their ability to buy and resell the drugs. Drugs purchased on site usually come with a QR code on their packaging to encourage users to purchase via delivery via Telegram or SnapChat, thus avoiding crowds at the location and not attracting much attention from authorities. Near the "fours", arrows will be found within a radius of 500 meters indicating the direction to follow until reaching the place where the drugs are sold, making it easier for new consumers to find them.
Normally when you arrive at the "Fours" you will find graffiti indicating some information such as the name of the place and opening hours. By searching the name of the place on social networks such as Telegram or SnapChat you will find the contact of one of the traders or a group where you can join and monitor the drugs available and the start and end times of activities daily.
These places are usually residential buildings where a drug dealer lives and brings other drug dealers to settle there. There are violent and armed people who force everyone living there to remain silent about the activities in the place. These places are always located in poorer regions and end up attracting young people to work in drug trafficking, either as a delivery person or as an observer who must monitor the access streets and shout out to drug dealers if they see the police. Unaccompanied young people and people helped by the government with social programs such as OQTF are the main employed by traffickers as they cannot be 10 detained, so if they are captured by the police they will be taken to the police station, released shortly afterwards and will return to their work activities. With the “Fours”, traffickers now have new possibilities to carry out Marketing campaigns, for example promoting themed parties on commemorative dates such like Halloween, Christmas and others.
2.3 Advertising campaigns conducted by drug dealers in France
Small traffickers who are just starting out in the market use communication channels such as Telegram, Instagram and establish individual or group contacts to promote their products and services. They often engage in social interactions in local communities, whether at parties, bars or other events, where they can establish contacts and build trust with potential consumers. Through these in-person interactions, dealers seek to create a loyal customer base that trusts them to provide quality products and personalized services. Traffickers also employ visual strategies to differentiate their photos and videos and avoid plagiarism and increase recognition of their products among consumers. This may include creating distinctive logos, symbols and designs associated with your products, as well as using custom packaging or labels to identify your merchandise. This visual investment can be crucial, as the quality and origin of products are uncertain for the consumer.
2.4 Collection of open source data on official crime websites in the field of drug trafficking (number of arrests/seizures over the last 3 years).
Increasing numbers over the years
In France, the number of arrests related to drug trafficking tends to grow every year, and in 2020 there was an average of 41.200, in 2021 there was an average of 46.700, in 2022 the average was 49.000 and in the year From 2023 there was a small drop in numbers, reaching an average of 48,300 arrests for drug trafficking across the country.
Arrests for drug use reach much higher numbers, which also tend to grow, with an average of 221.3000 in 2021, an average of 251.400 in 2022 and an average of 260.300 arrests for drug use in 2023 in country.
Focus on 2022
The balance sheet of drug seizures for 2022 reached historical levels.
For cannabis, more than 128.6 tonnes were seized in 2022 (+15% compared to 2021), setting a historical record. The threshold of 125 tonnes was exceeded for the first time. Resin accounts for 68% of seizures. The THC content in the resin continues to increase (30%). For cocaine, seizures increased by 5% to reach 27.7 tonnes. Over 10 years, they have multiplied by 5. 75% of seizures are made by maritime routes. 55% of seizures come from the Antilles and Guyana, storage and rebound areas for cocaine produced in South America. The average active ingredient content has never been higher (72%). For heroin, seizures amounted to 1.4 tonnes in 2022 (+8%). For synthetic drugs, France is both a transit and consumption area, whether it's ecstasy/MDMA, Ketamine, or new synthetic products. The consumption of new synthetic products is thus experiencing strong growth, leading to increased trafficking as illustrated by a seizure of 613 kg of cathinones by customs in Millau in January 2022. Consumption of new synthetic products, although still relatively limited, is growing.
• 3-MMC, whose consumption was until now reserved for very restricted circles (chemsex), is becoming more widespread among a larger audience, especially in festive environments. 3-MMC is a highly addictive product that causes delirious and depressive states, as well as somatic complications.
• 2-CB (pink cocaine), made up of several illicit substances (ketamine, MDMA, methamphetamine), is developing in parallel. Ecstasy/MDMA seizures are up by 6% (1,543,421 tablets seized). They have multiplied by 10 over 10 years. Finally, 273 kg of amphetamines and methamphetamine were seized (+21%). In 2022, in Paris, the Prefecture of Police services seized 657,000 ecstasy/MDMA tablets (compared to 99,800 in 2021).
Focus on mobilization in the fight against drugs
In 2022, 37,510 drug traffickers were implicated, compared to 35,829 in 2021, an increase of 4.7%. For January 2023 alone, 4,148 traffickers were implicated (+4% compared to December 2022). Nearly 15,160 operations to dismantle drug dealing points were conducted, compared to 5,849 in 2021 (+159%). Over 2,000 operations are conducted each month, compared to 900 counted at the beginning of 2022. Between the 4th quarter of 2020 and the 4th quarter of 2022, the number of drug dealing points identified by OFAST decreased from 4,034 to 3,159 (−22%). Lastly, as fighting against drugs also means combating consumption, the number of fixed penalty notices (AFD) issued increased from 106,476 in 2021 to 143,447 in 2022 (+34%). Since its inception, more than 298,000 AFDs have been issued by law enforcement, including 288,000 for cannabis, 8,400 for cocaine, and 1,400 for ecstasy/MDMA.
Top 10 departments issuing the most AFDs in 2022:
Seine-Maritime 3,960
Hérault 4,058
Hauts-de-Seine 4,567
Yvelines 4,848
Seine-et-Marne 4,867
Nord 6,063
Rhône 6,114
Seine-Saint-Denis 6,391
Paris 8,982
Bouches-de-Rhône 19,718
The number of people implicated for drug use rose to 249,800 in 2022, an increase of 13% compared to 2021 following a 38% increase in 2021, the year following the lockdown.
Balance of CROSS and the reporting platform
In 2022, the Cells for Operational Intelligence on Drugs (CROSS), located in each department, responsible for capturing and circulating operational intelligence on drugs, received 11,214 pieces of information, of which 4,476 resulted in an intelligence report (40%). These reports led to 1,491 judicial procedures and 103 customs procedures (judicialization rate: 33.3%). These procedures notably led to:
• 3,103 detentions, following which 1,092 individuals were incarcerated;
• the dismantling of 376 networks;
• seizures of 16 tonnes of cannabis, 3.4 tonnes of cocaine, 141 kg of heroin, 162 kg of synthetic drugs, 407 weapons, 216 vehicles, and over €11 million in criminal assets.
Since the implementation of the reporting platform on moncommissariat.fr, 17,559 reports have been filed. Among the 1,491 judicial procedures opened in 2022, 43.7% were initiated or enriched by the reporting portal (i.e., 652).
Implementation of a security approach for logistics platforms
Customs, the Ministry of Transport (DGITM), OFAST, the Judicial Authority, the General Secretariat of the Sea, and prefectural authorities are implementing a security approach for French logistics platforms, particularly container terminals. This approach aims to improve the protection of logistics facilities against criminal infiltrations while strengthening the control capacity of customs services within port terminals. To this end, a unique plan for equipping ports is being conducted, aiming for the deployment of mobile scanners in major ports from 2024, notably in Le Havre, Marseille, Dunkirk, Saint-Nazaire, and the Antilles. Finally, customs, in close cooperation with OFAST and the Judicial Authority, is actively fighting against criminal infiltration of logistics platforms. Several criminal networks operating at the heart of ports, airports, and express freight centers were dismantled in 2022.
An indication minimum and maximum sentences for sales, purchasing and possession of illegal drugs
Here is a summary of the penalties incurred for possession and trafficking of drugs in France:
For possession:
- Cannabis:
- Up to 1 year in prison and €3,750 fine for use
- Up to 10 years in prison and €7,500,000 fine for possession
- Cocaine, ecstasy, heroin:
- Up to 10 years in prison and €7,500,000 fine for use
- Up to 10 years in prison and €7,500,000 fine for possession
For trafficking:
- Cannabis:
- Up to 10 years in prison and €7,500,000 fine
- Cocaine, ecstasy, heroin:
- Up to life imprisonment and €7,500,000 fine
- Aggravating circumstances (organized gang, use of a minor, etc.): increased penalties
- The penalty depends on the quantity of drugs, with thresholds set by law.
Penalties can be adjusted depending on the circumstances and at the discretion of the judge. Recidivism also results in heavier sanctions.
2.5 Illegal popular drugs in France
The most popular drugs in France are:
• Cannabis: the most widespread drug with 17 million French people having consumed it at least once, and 1.4 million consuming it regularly.
• Cocaine: approximately 600,000 users in the year according to the OFDT.
• Ecstasy and other synthetic drugs: around 500,000 users in the year according to the OFDT.
• Heroin: between 150,000 and 180,000 users according to a study published in 2013.
• Poppers: about 400,000 regular consumers.
• Hallucinogenic mushrooms: around 700,000 experimenters in France according to a 2015 study.
• LSD: approximately 1.1 million people have tried it.
It can be observed that cannabis overwhelmingly dominates the drug market in France. Cocaine is far behind but seems to be spreading more, especially in festive environments and in certain large cities.
2.6 Legal popular drugs in your country (what popular drugs are legal in France and where they can be purchased legally online/offline)
• Salvia divinorum, a plant whose use induces intense hallucinations, ipomoea tricolor, nutmeg, kratom, and datura, the latter being highly toxic and commonly used as an indoor or outdoor plant for its decorative appearance.
• Medications: Medications can be used recreationally, particularly benzodiazepines (Lexomil, Valium), used for their side effects (intoxication, euphoria, deep relaxation, feeling "mushy"). Zolpidem, a benzodiazepine derivative better known as "Ambien," is a drug notably popular in the United States, where numerous web-posted videos depict its effects (intense relaxation, hallucinations, euphoria, etc.). Other opioid medications containing codeine or tramadol are also consumed recreationally, especially tramadol, which, in addition to the effects of opioids, affects serotonin reuptake, similarly to many antidepressants. While these medications require a medical prescription, they are easily accessible, making them a somewhat legal drug, even though their recreational use is prohibited. The dissociative dextromethorphan (DXM) is legal but requires a prescription from a physician.
• Solvents: Many solvents, such as diethyl ether, gasoline, butane, nitrous oxide, as well as certain glues, aerosols, or chemical cleaners, are used by drug users or young teenagers to "get high." Solvents are considered "dirty drugs," extremely dangerous when inhaled, as their mode of action, unlike other drugs that act on receptors, is to destroy neurons, resulting in a "shooting" effect. They can be found in stores.
• CBD: Cannabidiol, also known as CBD, is a drug legalized in France and can be found in CBD shops.
3. A characteristic of the offline drug trading in France.
The offline drug trade in France is characterized by rampant expansion, where traffickers thrive despite law enforcement efforts. Massive seizures of cocaine and cannabis indicate a flourishing activity, fueled by sophisticated networks established in urban areas in connection with Morocco or other places like Guyana for cocaine. These organizations do not hesitate to resort to violence and corruption to protect their interests. Furthermore, the diversification of products and the adoption of modern marketing strategies, such as home deliveries, enhancing products (selling adulterated goods, offering extra gifts), and the ease of selling at the bottom of housing estates with "Drive" systems, for example, where one orders merchandise directly from the car and collects it a bit further on, along with promotion on social networks (Snap and Telegram) as previously explained, demonstrate traffickers' adaptation to market demands and technological advancements.
3.1 A list of all known geographical points of attraction for drug users.
History of drug trafficking: Marseille has a long history associated with drug trafficking, dating back to the 1980s when the Corsican-Marseillais underworld dominated the city's criminal landscape. Since then, drug trafficking has evolved, now involving diverse ethnic groups, particularly of Maghreb and Comorian origin.
Role of the northern districts: The northern districts of Marseille are often cited as hotspots for drug trafficking. These areas, characterized by unemployment, school dropouts, and poverty, have seen the emergence of a "survival economy" in response to social marginalization.
Drug trafficking: France has 3,952 drug dealing points
The result, both spectacular and alarming, confirms the magnitude of the task in the battle against narcotics that law enforcement agencies aim to wage, from international operations to apartment building hallways. According to figures we exclusively reveal, France would now have 3,952 drug dealing points. This unprecedented compilation reveals the extent of the phenomenon. In mainland France, only Lozère and Hautes-Alpes, according to the Interior Ministry, have no registered points. This does not mean that cannabis cannot be found there, but in these departments, sales are more through word of mouth or on-the-fly rather than in a real fixed sales point.
Seine-Saint-Denis, Rhône, and Nord lead the way
Conversely, not surprisingly again, major urban centers are much more affected by the presence of these marijuana and cocaine sellers. At the top of this dark ranking is Seine-Saint-Denis, which would have 276 drug dealing points. "It's the number one scourge of the department," says a magistrate stationed in the 93. "It disrupts a part of the youth attracted by easy money. Some young people can't even imagine doing anything other than dealing, which can only lead them to death or prison." "In some neighborhoods of the department, as soon as there's a stairwell, there's a sales location," adds a senior official, who believes the figure of 276 is rather optimistic.
Rhône and Nord complete the podium with over 250 places to source narcotics. Other Île-de-France departments also rank well in the list, with between 66 drug plans in Paris and 128 in Val-d'Oise. "In large cities, the clientele is significant, and drugs are the most lucrative criminal activity," emphasizes a specialized police officer. "Trafficking supports many people, and a drug dealing point can generate up to 50,000 euros a day."
Surprisingly, away from major cities, some departments have a high concentration. This is notably the case in Vaucluse and Loiret, recipients of Parisian and Marseille plates, where there would be 15 and 10 drug dealing points per 100,000 inhabitants respectively. Overseas, Guadeloupe and Martinique are also plagued, with 129 and 50 dealing points for just over 350,000 inhabitants respectively.
In the maps below we see all the regions affected by crimes related to drug trafficking and consumption in France in 2019 when the numbers were last publicly released. When monitoring the news related to the subject it is possible to see that the regions shown on the map had the tendency to maintain the same numbers and, in some regions, there is an upward trend since the last public release.
In particular, there was a large increase in drug trafficking in some regions, which made the government invest its efforts in combating drug trafficking more rigorously in these locations. The map below shows the main locations known for drug trafficking in France.
4. A comprehensive list of thematic and near-thematic websites/Telegram groups, or channels/communities in Discord, or any other social networks covering news related to drug use and drug business in France.
Web News :
Discord :
Telegram :
Snapchat :
5. A list of the most known anonymous ways to purchase cryptocurrencies in your country. A list of popular payment systems used by fraudsters and drug dealers. General estimation of the cryptocurrencies using for drugs purchasing.
Buying cryptocurrencies anonymously in France can be challenging due to current heavy regulations that require users to identify themselves. However, it is still possible to purchase cryptocurrencies online relatively anonymously through the following platforms that currently do not require KYC to initiate transactions:
• https://hodlhodl.com/
• https://paxful.com/fr
• https://localcoinswap.com/
• https://learn.robosats.com/
Another option is to use cryptocurrency ATMs. These tellers often allow you to purchase cryptocurrencies in cash without needing to provide personal information. It is possible to locate all ATMs in France through this website:
• https://coinatmradar.com/country/73/bitcoin-atm-france/
Other exemples commonly used by vendors on Whatsapp :
6. A presence of any illegal drugs delivery to door services in France.
Telegram accounts
7. Describe a portrait of an average drug user and an average drug dealer.
Dealers:
Users:
figure 9: Consumption of drugs by Age
8. Chemical reagents and equipment stores
https://www.servilab.fr/panier
https://www.labomoderne.com/
https://jeulin.com/lelaborantin_fr/
https://www.nadal-alcools.com/produit/bouteille-d-1-litre-dalcool-90-pour-fruits/
https://www.amazon.fr/éthanol/s?k=éthanol
https://www.labs24.net/
https://www.mon-droguiste.com/produit-chimique/liquide
https://www.arcane-direct.com/fr/23-degraissant-par-aspersion
https://chemical.center/fr/les-bases/7-lessive-de-soude-305
9. Drug news
Among young French people there is a great interest in finding out about the evolution of laws regarding flexibility in consumption, especially in relation to marijuana. Some of the portals used to stay up to date are:
• https://discord.gg/sQw7pjW2BK
• https://www.royalqueenseeds.fr/blog
• https://www.zamnesia.fr/blog
• https://www.growbarato.net/blog/
• https://www.sciencesetavenir.fr/
• https://www.cannaconnection.com/fr/blog
• https://www.lefigaro.fr/
• https://www.cbd.fr/blog/
• https://www.huffingtonpost.fr/
• https://lecannabiste.com/
• https://disboard.org/fr/server/join/1015479909054943323
• https://disboard.org/fr/server/join/443788004704649236
• https://www.newsweed.fr/
List of illicit drugs
In France, the substances and preparations mentioned below are classified as narcotic drugs:
Decree of 22 February 1990 laying down the list of substances classified as narcotics
Modified by decree on October 14, 2019
Annex I
Annex II
This annex includes:
- the substances below designated;
- their isomers, with express exceptions, in all cases where they may exist, in accordance with the corresponding chemical formula of the said substances;
- the salts of said substances and their isomers in all cases where they may exist;
- their preparations named below;
Annex III
This annex includes:
- the substances below designated;
- their stereo-isomers, in all cases where they may exist in accordance with the specified chemical designation, for substances preceded by an asterisk;
- their salts in all cases where they may exist;
- the preparations of these substances, with the exception of the one named below;
Annex IV
This annex includes the following designated products and their preparations:
- with a grouping (otherwise substituted or not), on the carbon of the methane bridge of the type naphthyl, benzyl, phenyl, cyclopropyl, adamantyl.
In particular:
- with a substitute on nitrogen in position 1 of the indazole nucleus of the alkyl, haloalkyl, halobenzyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, methyl-oxane, 1-(N-methylpiperidin-2-yl) methyl or 2-(4-morpholinyl) ethyl type;
- with a grouping (otherwise substituted or not), on the carbon of the methane bridge of the type naphthyl, benzyl, phenyl, cyclopropyl, adamantyl.
In particular:
- with a substitute on the nitrogen of the pyrrole nucleus such as alkyl, haloalkyl, halobenzyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, methyl-oxane, or 2-(4-morpholinyl) ethyl;
- that the pyrrole nucleus is otherwise substituted or not;
- whoether the naphthyl nucleus is otherwise substituted or not.
In particular:
- with a substitute on the nitrogen of the indole nucleus such as alkyl, haloalkyl, halobenzyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, methyl-oxane, 1-(N-methylpiperidin-2-yl) methyl or 2-(4-morpholinyl) ethyl;
- whoever the indole nucleus is otherwise substituted or not;
- whoether the naphthyl nucleus is otherwise substituted or not.
In particular:
- with a substitute in position 3 of the indene nucleus such as alkyl, haloalkyl, halobenzyl, alkenyl, cycloalkylmethyl, methyl-oxane, cycloalkylethyl, 1-(N-methylpiperidin-2-yl) methyl or 2-(4-morpholinyl) ethyl;
- whoever the indene nucleus is otherwise substituted or not;
- whoether the naphthyl nucleus is otherwise substituted or not.
In particular:
- JWH-176 or 1-([(1E)-3-pentylinden-1-ylidine] methyl) naphthalene.
- Cyclohexylphenols or derivatives of 2-(3-hydroxycyclohexyl) phenol
- with a substitute in position 5 of the phenol nucleus type alkyl, haloalkyl, halobenzyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, methyl-oxane, 1-(N-methylpiperidin-2-yl) methyl or 2-(4-morpholinyl) ethyl;
- whoever the cyclohexyl core is otherwise substituted or not.
In particular:
- with a substitute on the nitrogen of the indol nucleus such as alkyl, haloalkyl, halobenzyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, methyl-oxane, 1-(N-methylpiperidin-2-yl) methyl or 2-(4-morpholinyl) ethyl;
- whoever the indole nucleus is otherwise substituted or not;
- with a grouping (otherwise substituted or not), on the oxygen of the carboxylate bridge of the 8-quinolinyl or 1-naphthalenyl type.
In particular:
- with a substitute on nitrogen in position 1 of the indazole nucleus such as alkyl, haloalkyl, halobenzyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, methyl-oxane, 1-(N-methylpiperidin-2-yl) methyl or 2-(4-morpholinyl) ethyl;
- whether the indazole nucleus is otherwise substituted or not;
- with a grouping (otherwise substituted or not), on the oxygen of the carboxylate bridge of the 8-quinolinyl or 1-naphthalenyl type.
In particular:
- with a substitute on the nitrogen of the indol nucleus such as alkyl, haloalkyl, halobenzyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, methyl-oxane, 1-(N-methylpiperidin-2-yl) methyl or 2-(4-morpholinyl) ethyl;
- whoever the indole nucleus is otherwise substituted or not;
- with the nitrogen of the carboxamide bridge integrated into a cycle or carrying a substitute of the cumyl, naphthyl, adamantanyl, benzyl, bicyclo [2.2.1] heptanyl type, or carrying a group of type 1-alkoxy-1-oxo-butan-2-yl, 1-amino-1-oxo-butan-2-yl, whether or not this group is itself substituted in position 3 by one or two alkyl, cycloalkyl or phenyl type substitutes.
In particular:
- with a substitute on nitrogen in position 1 of the indazole nucleus such as alkyl, haloalkyl, halobenzyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, methyl-oxane, 1-(N-methylpiperidin-2-yl) methyl or 2-(4-morpholinyl) ethyl;
- whether the indazole nucleus is otherwise substituted or not;
- with the nitrogen of the carboxamide bridge integrated into a cycle or carrying a substitute of the cumyl, naphthyl, adamantanyl, benzyl, bicyclo [2.2.1] heptanyl type, or carrying a group of type 1-alkoxy-1-oxo-butan-2-yl, 1-amino-1-oxo-butan-2-yl, whether or not this group is itself substituted in position 3 by one or two alkyl, cycloalkyl or phenyl type substitutes.
In particular:
- with a substitute on nitrogen in position 1 of the pyrrolo [3,2-c] pyridine nucleus such as alkyl, haloalkyl, halobenzyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, methyl-oxane, 1-(N-methylpiperidin-2-yl) methyl or 2-(4-morpholinyl) ethyl;
- whether the pyrrolo [3,2-c] pyridine nucleus is otherwise substituted or not;
- with a substitute on the nitrogen of the naphthyl-type carboxamide bridge, substituted or not.
In particular:
- with a substitute on the nitrogen of the indol nucleus such as alkyl, haloalkyl, halobenzyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, methyl-oxane, 1-(N-methylpiperidin-2-yl) methyl or 2-(4-morpholinyl) ethyl;
- whoever the indole nucleus is otherwise substituted or not;
- whoever the thiazole nucleus is otherwise substituted or not.
In particular:
- a substituent alkyl, phenyl, alkoxy, alkylenedioxy, haloalkyl, halogenated on the phenyl cycle;
- an alkyl substituent in position 3;
- an alkyl or dialkyl or cyclic substituent on nitrogen; with the exception of bupropion.
Any structure derived from 2-amino-1-one propane by substitution in position 1 with any monocyclic or polycyclic system, as well as its salts and stereoisomers.
In particular:
- amfepramone or diethylpropion or 2-diethylamino-1-phenylpropan-1-one;
- benzedrone or 4-MBC or methylbenzylcathinone or 1-(4-methylphenyl)-2-benzylaminopropan-1-one;
- BMDB or 2-benzylamino-1-(3,4-methylenedioxyphenyl) butane-1-one;
- BMDP or 3,4-MDBC or 2-benzylamino-1-(3,4-methylenedioxyphenyl) propane-1-one;
- brephedrone or 4-bromomethcathinone or 4-BMC or 1-(4-bromophenyl)-2-methylaminopropan-1-one;
- buphedrone or 2-(methylamino)-1-phenylbutan-1-one;
- butylone or bk-MBDB or 2-methylamino-1-(3,4-methylenedioxyphenyl) butan-1-one;
- dibutylone or methylbutylone or bk-MBDB or 2-dimethylamino-1-(3,4-methylenedioxyphenyl) butan-1-one;
- dimethylone or bk-MDDMA or 1-(1,3-benzodioxol-5-yl)-2-(dimethylamino) propane-1-one;
- 3,4-DMMC or 1-(3,4-dimethylphenyl)-2-(methylamino) propane-1-one;
- 4-EMC or 4-ethylmethcathinone or 2-methylamino-1-(4-ethylphenyl) propane-1-one;
- ethylcathinone or ethylpropion or 2-ethylamino-1-phenyl-propane-1-one;
- 4-ethylmethcathinone or 4-EMC or 2-methylamino-1-(4-ethylphenyl) propane-1-one;
- phlephedrone or 4-FMC or 4-fluoromethcathinone or 2-methylamino-1-p-fluorophenyl-propan-1-one;
- 3-FMC or 3-fluoromethcathinone or 2-methylamino-1-(3-fluorophenyl) propane-1-one;
- iso-ethcathinone or 1-ethylamino-1-phenyl-propane-2-one;
- iso-pentedrone or 1-methylamino-1-phenyl-pentan-2-one;
- MDMPP or 1-(3,4-methylenedioxyphenyl)-2-methyl-2-pyrrolidinyl-1-propanone;
- MDBPP or 1-(3,4-methylenedioxyphenyl)-2-(1-pyrrolidinyl)-1-butanone;
- MDPPP or 1-(3,4-methylenedioxyphenyl)-2-(1-pyrrolidinyl)-1-propanone;
- MDPV or MDPK or 1-(3,4-methylenedioxyphenol)-2-pyrrolidinyl-pentan-1-one;
- mephedrone or 4-MMC or methylmethcathinone or 2-ethylamino-1-(4-methylphenyl) propane;
- metamfepramone or dimethylcathinone or dimethylpropion or 2-dimethylamino-1-phenylpropan-1-one;
- methcathinone or ephedrone or 2-(methylamino)-1-phenyl-propane-1-one;
- methedrone or PMMC or 4-methoxymethcathinone or bk-PMMA or 1-(4-methoxyphenyl)-2-(methylamino) propane-1-one;
- 4-methylbuphedrone or 4-Me-MABP or bk-N-methyl-4-MAB or 2-(methylamino)-1-(4-methylphenyl) butan-1-one;
- methylone or MDMCAT or bk-MDMA or 2-methylamino-1-[3,4-methylenedioxyphenyl] propane-1-one;
- MOPPP or 4'-methoxy-alpha-pyrrolidinopropiophenone;
- MPBP or 1-(4-methylphenyl)-2-(1-pyrrolidinyl)-1-butanone;
- MPHP or 4'-methyl-alpha-pyrrolidinohexanophenone;
- MPPP or 4'-methyl-alpha-pyrrolidinopropiophenone;
- naphyrone or naphthylpyrovalerone or 1-naphthalene-2-yl-2-pyrrolidin-1-ylpentan-1-one;
- 1-naphyrone or 1-naphthalene-1-yl-2-pyrrolidine-1-ylpentan-1-one;
- N-ethyl buphedrone or NEB or 2-ethylamino-1-phenylbutan-1-one;
- pentylone or bk-MBDB or 2-methylamino-1-(3,4-methylenedioxyphenyl) pentan-1-one;
- PPP or 1-Phenyl-2-(1-pyrrolidinyl)-1-propanone;
- Pyrovalerone or 1-(4-methylphenyl)-2-(1-pyrrolidinyl) pentan-1-one.
- substituted on the phenyl cycle in any way;
and
- substituted on the amine group by at least one benzyl group, with an alkoxy, alkylenedioxy, halogenated or hydroxy substituent on the phenyl cycle.
In particular:
- 4-methoxybutyr (yl) fentanyl;
- beta-hydroxythiofentanyl;
- despropionylfentanyl;
- despropionyl-2-fluorofentanyl;
- isobutyr (yl) fentanyl;
- methoxyacetylfentanyl;
- para-chloroisobutyrfentanyl or 4-chloroisobutyrfentanyl;
- tetrahydrofuranylfentanyl or THF-F;
- valerylfentanyl;
- Diphenidine or 1-(1,2-diphenylethyl) piperidine or 1,2-DEP or DPD or DND;
- Ephenidine or N-ethyl-1,2-diphenylethylamine or NEDPA or EPE;
- Methoxphenidine or methoxyphenidine or 1-[1-(2-methoxyphenyl)-2-phenylethyl] piperidine or
- substituted by an alpha ethylamine group regardless of its position on the benzofuran nucleus, whether or not the ethylamine function is itself substituted on nitrogen by one or more alkyl groups and/or substituted or not in the alpha position by an alkyl group;
- substituted or not otherwise by an alkoxy group.
In particular:
Any molecule derived from the 2,3-dihydrobenzofuran nucleus:
- substituted by an alpha ethylamine group regardless of its position on the 2,3-dihydrobenzofuran nucleus, whether or not the ethylamine function is itself substituted on nitrogen by one or more alkyl groups and/or substituted or not in alpha position by an alkyl group;
- substituted or not otherwise by an alkoxy group.
In particular:
Sources
1.
1.1.A
1.1.B
1.3
1.4
2.
2.1
2.5
4.
By @Magicshroom et @France
1.1.A List of illicit drugs
See the full list in Annex 1
• Cannabis is today the most consumed illegal drug in the country. In the following graph, we can see the evolution of cannabis consumption levels between 1992 and 2021, amongst people aged from 18 to 64 (in %)
• Cocaine, MDMA/Ecstasy, Mushrooms, Amphetamines and Heroin are the most popular drugs after cannabis. See belox, the evolution of consumption over the years (between 1992 and 2017) amongst people aged from 18 to 64 (in %).
Drug use is regularly measured by various organizations, such as Public Health France (SPF) or the French Observatory on Drugs and Addiction Trends (OFDT). The latter also produces analyzes on these uses with the aim of “enlightening public authorities, professionals in the field and the general public about the phenomenon of drugs and addictions”, says service-public.fr. 22 Illegal drugs can be found in "fours", where at first you will buy in person and then you can place orders via social media using the QR code that will be on the drug's packaging. Or if a friend or family member has ordered before, you can ask for their contact to place orders.
1.2. Price of most common illicit drugs
| Retail | Wholesale | |
| Weed 100% dutch THC 20-24% | 25g = 160€ | 1kg = 5200€ |
| Hash 100% Morocco | 25g = 100€ | 500g = 1250€ |
| Cocaine 100% Columbia | 1g = 50€ | 100g = 3000€ |
| Ecstasy | 50pills = 150€ | 500pills = 1500€ |
| MDMA | 3g = 100€ | 100g = 1800€ |
| Mushrooms | 30g = 100€ | 1kg = 1800€ |
| Xanax | 200 pills 2mg = 110€ | 20000 pills 2mg = 4250€ |
figure 1: Magic Mushroom prices ( sources telegram)
figure 2: Magic Mushroom hash prices ( sources telegram)
figure 3: Magic Mushroom xanax prices ( sources telegram)
figure 4: Magic Mushroom Cocaine prices ( sources telegram)
figure 5: Magic Mushroom Ecstasy prices ( sources telegram)
1.3. Principles by which are determined the status of the substances
In France, the National Agency for the Safety of Medicines and Health Products (ANSM) is one of the main agencies responsible for conducting scientific assessments of the risks associated with drugs and medications. These assessments cover various aspects, including the effects on physical and mental health, the risks of dependence, side effects, and drug interactions. The conclusions of these assessments are often used to inform regulatory decisions regarding the classification and regulation of substances. However, it should be noted that ANSM is not the only agency or mechanism involved in determining the status of substances in France.
In addition to assessments conducted by ANSM and other similar organizations, several other mechanisms can be used to determine the status of substances in France. This may include political, economic, and social considerations, as well as pressure from consumer rights groups or special interest groups. Furthermore, recommendations and decisions from international organizations, such as the World Health Organization (WHO) for globally controlled substances, can also influence substance classification. Centers for Evaluation and Information on Pharmacodependence-Addictovigilance (CEIP-A) also play a crucial role in assessing the risks and monitoring the use of addictive substances in France.
1.4 List of legal drugs
• Alcohol
• Tobacco
• Painkillers
• Sleeping pills
• Glues
• Solvents
These are the most popular drugs in France that you can buy legally in stores such as supermarkets, tobacconists, pharmacies and other everyday stores. Despite being legal, there are laws and regulations in force in France that restrict the consumption or purchase of certain legal drugs on specific days, times and quantities.
For example, alcohol sales are prohibited between 22:00 and 08:00 and at gas stations between 18:00 and 08:00, in accordance with local regulations intended to reduce excessive drinking and public disturbances.
1.5 Lists of controlled chemicals (drug precursors)
See full list in Annex 2
CATEGORY 1
| Product | Code CAS | Code NC | Used for | Type |
| N-acetylanthranilic acid (2-acetamidobenzoic acid) and its salts | 89-52-1 | 2924 23 00 | Methaqualone Mecloqualone | Precursor |
| Alpha-phenylacetoacetonitrile (APAAN) | 4468-48-8 | 2926 90 95 | Phenyl-1 propanone-2 | Precursor Classified poisonous substance |
| Ephedrine and its salts | 299-42-3 | 2939 41 00 | Methamphetamines | Precursor |
| Ergometrine and its salts | 60-79-7 | 2939 61 00 | LSD | Precursor |
| Ergotamine and its salts | 113-15-5 | 2939 62 00 | LSD | Precursor |
| Sassafras oil | 8006-80-2 | 3301 29 41 3301 29 91 | Safrole MDA; MDMA; MDEA | Precursor |
| Isosafrole (cis + trans) and its salts | 120-58-1 | 2932 91 00 | MDA; MDMA; MDEA | Precursor |
| 3, 4-Methylenedioxy-phenylpropan-2-one and its salts (1-(1,3-Benzodioxole-5-yl) propane-2-one or 3,4-MDP-2-P or MD3.4P2 or PMK) | 4676-39-5 | 2932 92 00 | MDA; MDMA; MDEA | Precursor |
| Lysergic acid and its salts | 82-58-6 | 2939 63 00 | LSD | Precursor and psychotropic |
| Norephedrine and its salts (phenylpropanolamine) | 14838-15-4 | 2939 44 00 | Amphetamine | Precursor |
| Phenyl-1-propanone-2 and its salts (P2P or Phenylacetone or BMK) | 103-79-7 | 2914 31 00 | Amphetamine Methamphetamine | Precursor and psychotropic |
| Piperonal and its salts | 120-57-0 | 2932 93 00 | MDA; MDMA; MDEA | Precursor |
| Pseudoephedrine and its salts | 90-82-4 | 2939 42 00 | Amphetamine Methamphetamine | Precursor |
| Safrole and its salts | 94-59-7 | 2932 94 00 | MDA; MDMA; MDEA | Precursor |
CATEGORY 2-A
| Product | Code CAS | Code NC | Used for | Type | (Register operator) Exemption if the annual threshold does not exceed: | (Register of user) Exemption if the annual threshold does not exceed: |
| Acetic anhydride | 108-24-7 | 2915 24 00 | P2P Heroine Methaqualone | Précurseur | 100L | 100L |
CATEGORY 2-B
| Product | Code CAS | Code NC | Used for | Type | (Register operator) Exemption if the annual threshold does not exceed: |
| Anthranilic acid and its salts | 118-92-3 | 2922 43 00 | Methaqualone | Precursor | 1 Kg |
| Phenylacetic acid and its salts | 103-82-2 | 2916 34 00 | Amphetamines Methamphetamines | Precursor | 1 Kg |
| Potassium permanganate | 7722-64-7 | 2841 61 00 | Cocaine | Chemical product essential | 100 Kg |
| Piperidine and its salts | 110-89-4 | 2933 32 00 | Phencyclidine | Precursor | 0,5 Kg |
CATEGORY 3
List of countries appearing in Annex IV, point II of Regulation (EC) No.225/2011
amending Regulation (EC) No. 1277/2005 of the Commission of July 27, 2005
| Product | Code CAS | Code NC | Used for | Type | (Register operator) Exemption if the annual threshold does not exceed: |
| Acetone | 67-64-1 | 2914 11 00 | Cocaine, Heroin | Chemical product essential | 50 Kg |
| Hydrochloric acid (1) (Hydrogen chloride) | 7647-01-0 | 2806 10 00 | Cocaine, Heroin | Chemical product essential | 100 Kg |
| Sulfuric acid (1) | 7664-93-9 | 2807 00 10 | Cocaine, Heroin | Chemical product essential | 100 Kg |
| Ethyl ether (Diethyl ether or diethyl oxide) | 60-29-7 | 2909 11 00 | Cocaine, Heroin | Chemical product essential | 20 Kg |
| Methyl ethyl ketone – MEK - (Butanone) | 78-93-3 | 2914 12 00 | Cocaine, Amphetamines | Chemical product essential | 50 Kg |
| Toluene | 108-88-3 | 2902 30 00 | Cocaine | Chemical product essential | 50 Kg |
CATEGORY 4
| Product | NC Denomination | Code NC | |
| Medicines and veterinary medicines containing ephedrine or its salts | Containing ephedrine or its salts (neither presented in dose form, nor packaged for retail) | 3003 40 20 | |
| ^^^^ | Containing ephedrine or its salts (presented in dose form – including those intended for cutaneous administration- or packaged for retail sale) | 3004 40 20 | |
| Medicines and veterinary medicines containing pseudoephedrine or its salts | Containing pseudoephedrine (INN) or its salts (neither presented in dose form, nor packaged for retail sale) | 3003 40 30 | |
| Containing pseudoephedrine (INN) or its salts (presented in dose form –y including those intended to be administered by skin- or packaged for retail sale) | 3004 40 30 |
1.6 The penalties for advertising online stores, selling illegal drugs
France's legislative framework regarding the trade and consumption of drugs is strict and encompasses a wide range of substances. French law divides drugs into different categories based on their potential for abuse and impact on public health. Laws regarding the trade and consumption of drugs in France are mainly governed by the Penal Code, the Public Health Code, and specific legislations on controlled substances. The illicit transfer or offering of drugs to a person for personal consumption is punishable by a prison sentence of five years and a fine of 75.000 euros. But prison sentences ranging from several years to decades, depending on the severity of the crime, the amount and type of drugs involved, as well as the specific circumstances of the case and the individual convicted, may face additional legal restrictions, such as a prohibition on consumption in certain commercial activities, access to certain technologies or even life imprisonment and a fine of up to 7,500,000 euros in more serious cases. Drugs are classified into different categories such as narcotics, psychotropic substances, and products under special control. The possession, sale, and trafficking of illegal drugs are punishable by law, with penalties ranging from heavy fines to imprisonment, depending on the quantity and nature of the drug involved. France also adopts a zero-tolerance approach regarding drug trafficking, especially concerning narcotics such as heroin and cocaine. Additionally, France has implemented measures to prevent drug consumption, including education and prevention programs, treatment for drug addicts, and the application of alternative penalties for non-violent users, such as participation in rehabilitation programs. 4 However, despite the strict enforcement of anti-drug laws, France faces persistent challenges related to drug trafficking and consumption, especially in densely populated urban areas. In relation to the consumer, whether of cannabis, ecstasy, cocaine or any other illicit psychoactive substance, consumption constitutes a crime punishable by a maximum sentence of 1 year in prison and a fine of €3,750. Since 2019, under article L.3421-1 of the public health code, the illicit use of narcotics can give rise to a fixed fine. Thus, a person arrested for drug use or possession of small quantities can receive a fixed fine of 200 euros issued immediately by the police, payment of this fine puts an end to any legal proceedings.
- Directing or organizing a group with the aim of producing, manufacturing, importing, exporting, transporting, holding, offering, transferring, acquiring, or illicitly using narcotics is punishable by life imprisonment and a fine of 7,500,000 euros. (Article 222-34 of the Penal Code)
- Illicit production or manufacturing of narcotics is punishable by 20 years of life imprisonment and a fine of 7,500,000 euros. These offenses are punishable by 30 years of life imprisonment and a fine of 7,500,000 euros when committed by an organized group. (Article 222-35 of the Penal Code)
- Illicit import or export of narcotics is punishable by 10 years of imprisonment and a fine of 7,500,000 euros. These offenses are punishable by 30 years of life imprisonment and a fine of 7,500,000 euros when committed by an organized group. (Article 222-36 of the Penal Code)
- Illicit transportation, possession, offering, transferring, acquiring, or use of narcotics is punishable by 10 years of imprisonment and a fine of 7,500,000 euros. (Article 222-37 of the Penal Code)
- Illicit offering or transferring of narcotics to an individual for personal consumption is punishable by 5 years of imprisonment and a fine of 75,000 euros. This penalty is increased to 10 years when narcotics are offered or transferred to minors. (Article 222-39 of the Penal Code)
- Money laundering of the proceeds from narcotics trafficking is punishable by 10 years of imprisonment and a fine of 750,000 euros. (Article 222-38 of the Penal Code)
2 A characterization of the drug business in France
2.1 A list compilation of local online sellers and traffic on their websites
Some of the most popular sites in France to buy from are:
Telegram : NiceWeedMarket ( 636 followers ) , Jaune mousseux Frenchweed ( 2K3 followers ), uberweed31 ( 676 followers )
Snapchat : Caliweed coffee 420, anna_emily411, weedhash4200, pablo_weed33 , goodl20233099
Whatsapp : +33 6 05 80 49 73
Darknet: Cocorico Market ( but he is down, exitscam from the owner )
Zamnesia: https://www.zamnesia.fr/
Philosopher Seeds: https://www.philosopherseeds.com/fr/
Shayana Shop: https://french.shayanashop.com/
Royal Queen Seeds: https://www.royalqueenseeds.fr/
2.2 Popular marketplaces in France and analysis of their sites/traffic
Darknet : Cocorico Market ( but he is down, exitscam from the owner, in the last update)
Telegram : Jaune mousseux Frenchweed ( 2.3K followers )
FrenchWeedChemsnotesplug ( 421 followers)
LA FRAPPE A YODA ( 3.9K followers)
Dzmafia ( 2633 followers )
Mistral38 Lyon (1.4K)
After small drug dealers increase their demand, they join forces with groups of traffickers who establish a small region as their area of activity and define a place for users to buy drugs in person in places known as “Fours” or ovens in English, thus increasing their ability to buy and resell the drugs. Drugs purchased on site usually come with a QR code on their packaging to encourage users to purchase via delivery via Telegram or SnapChat, thus avoiding crowds at the location and not attracting much attention from authorities. Near the "fours", arrows will be found within a radius of 500 meters indicating the direction to follow until reaching the place where the drugs are sold, making it easier for new consumers to find them.
Normally when you arrive at the "Fours" you will find graffiti indicating some information such as the name of the place and opening hours. By searching the name of the place on social networks such as Telegram or SnapChat you will find the contact of one of the traders or a group where you can join and monitor the drugs available and the start and end times of activities daily.
These places are usually residential buildings where a drug dealer lives and brings other drug dealers to settle there. There are violent and armed people who force everyone living there to remain silent about the activities in the place. These places are always located in poorer regions and end up attracting young people to work in drug trafficking, either as a delivery person or as an observer who must monitor the access streets and shout out to drug dealers if they see the police. Unaccompanied young people and people helped by the government with social programs such as OQTF are the main employed by traffickers as they cannot be 10 detained, so if they are captured by the police they will be taken to the police station, released shortly afterwards and will return to their work activities. With the “Fours”, traffickers now have new possibilities to carry out Marketing campaigns, for example promoting themed parties on commemorative dates such like Halloween, Christmas and others.
2.3 Advertising campaigns conducted by drug dealers in France
Small traffickers who are just starting out in the market use communication channels such as Telegram, Instagram and establish individual or group contacts to promote their products and services. They often engage in social interactions in local communities, whether at parties, bars or other events, where they can establish contacts and build trust with potential consumers. Through these in-person interactions, dealers seek to create a loyal customer base that trusts them to provide quality products and personalized services. Traffickers also employ visual strategies to differentiate their photos and videos and avoid plagiarism and increase recognition of their products among consumers. This may include creating distinctive logos, symbols and designs associated with your products, as well as using custom packaging or labels to identify your merchandise. This visual investment can be crucial, as the quality and origin of products are uncertain for the consumer.
2.4 Collection of open source data on official crime websites in the field of drug trafficking (number of arrests/seizures over the last 3 years).
Increasing numbers over the years
| Years → Drugs seizures ↓ | 2020 | 2021 | 2022 | 2023 |
| Weed (tons) | 96 tons | 109.3 tons | 128.6 tons (87.6% resin, 41% herb) | No official data yet |
| Cocaine (tons) | 13 tons | 26.3 tons | 27.7 tons | No official data yet |
| Heroin (tons) | 1.1 tons | 1.28 tons | 1.4 tons | No official data yet |
| Ecstasy/MDMA (number of pills) | 1.2 million of pills | >1.4 million of pills | >1.5 million of pills | 4.5 million of pills |
| Amphetamines and Methamphetamines (kg) | No data | 216kg | 273kg | 418kg |
| Number of dealers implicated | 22404 | 35829 | 37510 | No official data yet |
| AFD (Penalty fines for users and dealers) | No data | 106476 | 143447 | No official data yet |
| Operations to dismantle drug dealing spots. | 450 | 5849 | 15160 | No official data yet |
In France, the number of arrests related to drug trafficking tends to grow every year, and in 2020 there was an average of 41.200, in 2021 there was an average of 46.700, in 2022 the average was 49.000 and in the year From 2023 there was a small drop in numbers, reaching an average of 48,300 arrests for drug trafficking across the country.
Arrests for drug use reach much higher numbers, which also tend to grow, with an average of 221.3000 in 2021, an average of 251.400 in 2022 and an average of 260.300 arrests for drug use in 2023 in country.
Focus on 2022
The balance sheet of drug seizures for 2022 reached historical levels.
For cannabis, more than 128.6 tonnes were seized in 2022 (+15% compared to 2021), setting a historical record. The threshold of 125 tonnes was exceeded for the first time. Resin accounts for 68% of seizures. The THC content in the resin continues to increase (30%). For cocaine, seizures increased by 5% to reach 27.7 tonnes. Over 10 years, they have multiplied by 5. 75% of seizures are made by maritime routes. 55% of seizures come from the Antilles and Guyana, storage and rebound areas for cocaine produced in South America. The average active ingredient content has never been higher (72%). For heroin, seizures amounted to 1.4 tonnes in 2022 (+8%). For synthetic drugs, France is both a transit and consumption area, whether it's ecstasy/MDMA, Ketamine, or new synthetic products. The consumption of new synthetic products is thus experiencing strong growth, leading to increased trafficking as illustrated by a seizure of 613 kg of cathinones by customs in Millau in January 2022. Consumption of new synthetic products, although still relatively limited, is growing.
• 3-MMC, whose consumption was until now reserved for very restricted circles (chemsex), is becoming more widespread among a larger audience, especially in festive environments. 3-MMC is a highly addictive product that causes delirious and depressive states, as well as somatic complications.
• 2-CB (pink cocaine), made up of several illicit substances (ketamine, MDMA, methamphetamine), is developing in parallel. Ecstasy/MDMA seizures are up by 6% (1,543,421 tablets seized). They have multiplied by 10 over 10 years. Finally, 273 kg of amphetamines and methamphetamine were seized (+21%). In 2022, in Paris, the Prefecture of Police services seized 657,000 ecstasy/MDMA tablets (compared to 99,800 in 2021).
Focus on mobilization in the fight against drugs
In 2022, 37,510 drug traffickers were implicated, compared to 35,829 in 2021, an increase of 4.7%. For January 2023 alone, 4,148 traffickers were implicated (+4% compared to December 2022). Nearly 15,160 operations to dismantle drug dealing points were conducted, compared to 5,849 in 2021 (+159%). Over 2,000 operations are conducted each month, compared to 900 counted at the beginning of 2022. Between the 4th quarter of 2020 and the 4th quarter of 2022, the number of drug dealing points identified by OFAST decreased from 4,034 to 3,159 (−22%). Lastly, as fighting against drugs also means combating consumption, the number of fixed penalty notices (AFD) issued increased from 106,476 in 2021 to 143,447 in 2022 (+34%). Since its inception, more than 298,000 AFDs have been issued by law enforcement, including 288,000 for cannabis, 8,400 for cocaine, and 1,400 for ecstasy/MDMA.
Top 10 departments issuing the most AFDs in 2022:
Seine-Maritime 3,960
Hérault 4,058
Hauts-de-Seine 4,567
Yvelines 4,848
Seine-et-Marne 4,867
Nord 6,063
Rhône 6,114
Seine-Saint-Denis 6,391
Paris 8,982
Bouches-de-Rhône 19,718
The number of people implicated for drug use rose to 249,800 in 2022, an increase of 13% compared to 2021 following a 38% increase in 2021, the year following the lockdown.
Balance of CROSS and the reporting platform
In 2022, the Cells for Operational Intelligence on Drugs (CROSS), located in each department, responsible for capturing and circulating operational intelligence on drugs, received 11,214 pieces of information, of which 4,476 resulted in an intelligence report (40%). These reports led to 1,491 judicial procedures and 103 customs procedures (judicialization rate: 33.3%). These procedures notably led to:
• 3,103 detentions, following which 1,092 individuals were incarcerated;
• the dismantling of 376 networks;
• seizures of 16 tonnes of cannabis, 3.4 tonnes of cocaine, 141 kg of heroin, 162 kg of synthetic drugs, 407 weapons, 216 vehicles, and over €11 million in criminal assets.
Since the implementation of the reporting platform on moncommissariat.fr, 17,559 reports have been filed. Among the 1,491 judicial procedures opened in 2022, 43.7% were initiated or enriched by the reporting portal (i.e., 652).
Implementation of a security approach for logistics platforms
Customs, the Ministry of Transport (DGITM), OFAST, the Judicial Authority, the General Secretariat of the Sea, and prefectural authorities are implementing a security approach for French logistics platforms, particularly container terminals. This approach aims to improve the protection of logistics facilities against criminal infiltrations while strengthening the control capacity of customs services within port terminals. To this end, a unique plan for equipping ports is being conducted, aiming for the deployment of mobile scanners in major ports from 2024, notably in Le Havre, Marseille, Dunkirk, Saint-Nazaire, and the Antilles. Finally, customs, in close cooperation with OFAST and the Judicial Authority, is actively fighting against criminal infiltration of logistics platforms. Several criminal networks operating at the heart of ports, airports, and express freight centers were dismantled in 2022.
An indication minimum and maximum sentences for sales, purchasing and possession of illegal drugs
- The fixed penalty is a criminal sanction pronounced outside of a trial.
- The decision is made by a police officer, a gendarme, or an authorized public agent who observes this offense (customs officer...).
- Thus, if you are stopped by police officers or gendarmes while consuming illegal drugs. Forbidden drugs include, for example, cannabis, ecstasy, cocaine, LSD... or in possession of small quantities, you may receive a fixed penalty.
- This sanction consists of paying a sum of money to the Public Treasury.
- The amount of the fixed penalty is €200.
- The amount of the reduced fixed penalty is €150 if paid within 15 days.
- The amount of the fixed penalty is increased to €450 if not paid within 45 days.
- The illicit production or manufacture of drugs is punishable by twenty years of criminal imprisonment and a fine of €7,500,000.
- These offenses are punishable by thirty years of criminal imprisonment and a fine of €7,500,000 when committed by an organized gang.
- The first two paragraphs of Article 132-23 concerning the security period are applicable to offenses provided for by this article.
- The illicit import or export of drugs is punishable by ten years of imprisonment and a fine of €7,500,000.
- These offenses are punishable by thirty years of criminal imprisonment and a fine of €7,500,000 when committed by an organized gang.
- The transportation, possession, offer, sale, acquisition, or illegal use of drugs is punishable by ten years of imprisonment and a fine of €7,500,000.
- The same penalties apply to facilitating, by any means, the illegal use of drugs, obtaining drugs through fictitious or lenient prescriptions, or dispensing drugs upon presentation of such prescriptions while knowing their fictitious or lenient nature.
- Facilitating, by any means, the false justification of the origin of goods or income of the perpetrator of one of the offenses mentioned in Articles 222-34 to 222-37 or assisting in a laundering operation, concealment, or conversion of the proceeds of one of these offenses is punishable by ten years of imprisonment and a fine of €750,000. The fine can be raised up to half the value of the goods or funds involved in the laundering operations.
- When the offense concerns goods or funds from one of the crimes mentioned in Articles 222-34, 222-35, and 222-36, second paragraph, the perpetrator is punished with the penalties provided for the crimes of which he was aware.
- The illicit sale or offer of drugs to a person for personal consumption is punishable by five years of imprisonment and a fine of €75,000.
- The prison sentence is increased to ten years when drugs are offered or sold, under the conditions defined in the preceding paragraph, to minors or in educational or training establishments or in administrative premises, as well as, during the entry or exit of students or the public or at a very close time to these, near these establishments or premises.
Here is a summary of the penalties incurred for possession and trafficking of drugs in France:
For possession:
- Cannabis:
- Up to 1 year in prison and €3,750 fine for use
- Up to 10 years in prison and €7,500,000 fine for possession
- Cocaine, ecstasy, heroin:
- Up to 10 years in prison and €7,500,000 fine for use
- Up to 10 years in prison and €7,500,000 fine for possession
For trafficking:
- Cannabis:
- Up to 10 years in prison and €7,500,000 fine
- Cocaine, ecstasy, heroin:
- Up to life imprisonment and €7,500,000 fine
- Aggravating circumstances (organized gang, use of a minor, etc.): increased penalties
- The penalty depends on the quantity of drugs, with thresholds set by law.
Penalties can be adjusted depending on the circumstances and at the discretion of the judge. Recidivism also results in heavier sanctions.
2.5 Illegal popular drugs in France
The most popular drugs in France are:
• Cannabis: the most widespread drug with 17 million French people having consumed it at least once, and 1.4 million consuming it regularly.
• Cocaine: approximately 600,000 users in the year according to the OFDT.
• Ecstasy and other synthetic drugs: around 500,000 users in the year according to the OFDT.
• Heroin: between 150,000 and 180,000 users according to a study published in 2013.
• Poppers: about 400,000 regular consumers.
• Hallucinogenic mushrooms: around 700,000 experimenters in France according to a 2015 study.
• LSD: approximately 1.1 million people have tried it.
It can be observed that cannabis overwhelmingly dominates the drug market in France. Cocaine is far behind but seems to be spreading more, especially in festive environments and in certain large cities.
2.6 Legal popular drugs in your country (what popular drugs are legal in France and where they can be purchased legally online/offline)
• Salvia divinorum, a plant whose use induces intense hallucinations, ipomoea tricolor, nutmeg, kratom, and datura, the latter being highly toxic and commonly used as an indoor or outdoor plant for its decorative appearance.
• Medications: Medications can be used recreationally, particularly benzodiazepines (Lexomil, Valium), used for their side effects (intoxication, euphoria, deep relaxation, feeling "mushy"). Zolpidem, a benzodiazepine derivative better known as "Ambien," is a drug notably popular in the United States, where numerous web-posted videos depict its effects (intense relaxation, hallucinations, euphoria, etc.). Other opioid medications containing codeine or tramadol are also consumed recreationally, especially tramadol, which, in addition to the effects of opioids, affects serotonin reuptake, similarly to many antidepressants. While these medications require a medical prescription, they are easily accessible, making them a somewhat legal drug, even though their recreational use is prohibited. The dissociative dextromethorphan (DXM) is legal but requires a prescription from a physician.
• Solvents: Many solvents, such as diethyl ether, gasoline, butane, nitrous oxide, as well as certain glues, aerosols, or chemical cleaners, are used by drug users or young teenagers to "get high." Solvents are considered "dirty drugs," extremely dangerous when inhaled, as their mode of action, unlike other drugs that act on receptors, is to destroy neurons, resulting in a "shooting" effect. They can be found in stores.
• CBD: Cannabidiol, also known as CBD, is a drug legalized in France and can be found in CBD shops.
3. A characteristic of the offline drug trading in France.
The offline drug trade in France is characterized by rampant expansion, where traffickers thrive despite law enforcement efforts. Massive seizures of cocaine and cannabis indicate a flourishing activity, fueled by sophisticated networks established in urban areas in connection with Morocco or other places like Guyana for cocaine. These organizations do not hesitate to resort to violence and corruption to protect their interests. Furthermore, the diversification of products and the adoption of modern marketing strategies, such as home deliveries, enhancing products (selling adulterated goods, offering extra gifts), and the ease of selling at the bottom of housing estates with "Drive" systems, for example, where one orders merchandise directly from the car and collects it a bit further on, along with promotion on social networks (Snap and Telegram) as previously explained, demonstrate traffickers' adaptation to market demands and technological advancements.
3.1 A list of all known geographical points of attraction for drug users.
- Major urban areas, notably Paris, Marseille, Lyon, and Lille, where numerous drug dealing points and consumption areas are found due to the large population.
- Border areas, such as the Franco-Spanish border and the Franco-Belgian border, which are used for drug trafficking from other European countries.
- Coastal regions, like the French Riviera and the Mediterranean region, which serve as entry points for drugs from North Africa, for example, Marseille.
- Rural areas and small towns, where traffickers operate more discreetly but still actively, often taking advantage of less police surveillance.
- Nightlife areas, such as nightclubs and bars in major cities, where drug consumption is often associated with partying and nightlife.
History of drug trafficking: Marseille has a long history associated with drug trafficking, dating back to the 1980s when the Corsican-Marseillais underworld dominated the city's criminal landscape. Since then, drug trafficking has evolved, now involving diverse ethnic groups, particularly of Maghreb and Comorian origin.
Role of the northern districts: The northern districts of Marseille are often cited as hotspots for drug trafficking. These areas, characterized by unemployment, school dropouts, and poverty, have seen the emergence of a "survival economy" in response to social marginalization.
Drug trafficking: France has 3,952 drug dealing points
The result, both spectacular and alarming, confirms the magnitude of the task in the battle against narcotics that law enforcement agencies aim to wage, from international operations to apartment building hallways. According to figures we exclusively reveal, France would now have 3,952 drug dealing points. This unprecedented compilation reveals the extent of the phenomenon. In mainland France, only Lozère and Hautes-Alpes, according to the Interior Ministry, have no registered points. This does not mean that cannabis cannot be found there, but in these departments, sales are more through word of mouth or on-the-fly rather than in a real fixed sales point.
Seine-Saint-Denis, Rhône, and Nord lead the way
Conversely, not surprisingly again, major urban centers are much more affected by the presence of these marijuana and cocaine sellers. At the top of this dark ranking is Seine-Saint-Denis, which would have 276 drug dealing points. "It's the number one scourge of the department," says a magistrate stationed in the 93. "It disrupts a part of the youth attracted by easy money. Some young people can't even imagine doing anything other than dealing, which can only lead them to death or prison." "In some neighborhoods of the department, as soon as there's a stairwell, there's a sales location," adds a senior official, who believes the figure of 276 is rather optimistic.
Rhône and Nord complete the podium with over 250 places to source narcotics. Other Île-de-France departments also rank well in the list, with between 66 drug plans in Paris and 128 in Val-d'Oise. "In large cities, the clientele is significant, and drugs are the most lucrative criminal activity," emphasizes a specialized police officer. "Trafficking supports many people, and a drug dealing point can generate up to 50,000 euros a day."
Surprisingly, away from major cities, some departments have a high concentration. This is notably the case in Vaucluse and Loiret, recipients of Parisian and Marseille plates, where there would be 15 and 10 drug dealing points per 100,000 inhabitants respectively. Overseas, Guadeloupe and Martinique are also plagued, with 129 and 50 dealing points for just over 350,000 inhabitants respectively.
In the maps below we see all the regions affected by crimes related to drug trafficking and consumption in France in 2019 when the numbers were last publicly released. When monitoring the news related to the subject it is possible to see that the regions shown on the map had the tendency to maintain the same numbers and, in some regions, there is an upward trend since the last public release.
In particular, there was a large increase in drug trafficking in some regions, which made the government invest its efforts in combating drug trafficking more rigorously in these locations. The map below shows the main locations known for drug trafficking in France.
4. A comprehensive list of thematic and near-thematic websites/Telegram groups, or channels/communities in Discord, or any other social networks covering news related to drug use and drug business in France.
Web News :
- https://www.ouest-france.fr/societe/drogue/
- https://fr.statista.com/themes/3187/les-drogues-en-france/#topicOverview
- https://lecannabiste.com/
- https://www.zamnesia.fr/
- https://french.shayanashop.com/Champignons_Magiques-14-hc/ls-Champignons_Magiques-1024.aspx
- https://sensiseeds.com/fr
- https://www.magic-mushrooms-shop.com/fr/champignons-magique.html
- https://www.zativo.fr/
Discord :
- https://disboard.org/fr/server/1049529991731359844
- https://disboard.org/fr/server/692042296098816030
- https://disboard.org/fr/server/863454218500046908
- https://disboard.org/fr/server/1059357298725769236
- https://disboard.org/fr/server/1015479909054943323
- https://disboard.org/fr/server/804833104023912498
Telegram :
- Jaune mousseux Frenchweed ( 2K3 abonnés )
- FrenchWeedChemsnotesplug ( 421 abonnés)
- LA FRAPPE A YODA ( 3.9K abonnés)
- Dzmafia ( 2633 abonnés )
- Mistral38 Lyon (1,4K)
Snapchat :
- Caliweed coffee 420
- anna_emily411
- weedhash4200
- pablo_weed33
- goodl20233099
5. A list of the most known anonymous ways to purchase cryptocurrencies in your country. A list of popular payment systems used by fraudsters and drug dealers. General estimation of the cryptocurrencies using for drugs purchasing.
Buying cryptocurrencies anonymously in France can be challenging due to current heavy regulations that require users to identify themselves. However, it is still possible to purchase cryptocurrencies online relatively anonymously through the following platforms that currently do not require KYC to initiate transactions:
• https://hodlhodl.com/
• https://paxful.com/fr
• https://localcoinswap.com/
• https://learn.robosats.com/
Another option is to use cryptocurrency ATMs. These tellers often allow you to purchase cryptocurrencies in cash without needing to provide personal information. It is possible to locate all ATMs in France through this website:
• https://coinatmradar.com/country/73/bitcoin-atm-france/
Other exemples commonly used by vendors on Whatsapp :
- Exodus,
- Moonpay (eth & btc),
- RECHARGE.fr (PCS & NEOSURF),
- Bitnovo,
- bridge wallet,
- Trust wallet
- Neosurf tickets
6. A presence of any illegal drugs delivery to door services in France.
Telegram accounts
- LA FRAPPE A YODA
- DZ MAFIA
- Uber Weed31
- Jaune Mousseux Frenchweed | Parisweed
- WeedLyon
- MarseilleWeedSupply
- NiceWeedMarket
7. Describe a portrait of an average drug user and an average drug dealer.
Dealers:
| Age | 74% are less than 30 |
| Nationality | 85% French nationality and second nationality most represented is Algerian |
| Sex | 90% males |
| Social group | Precarious |
| Ethnicity | Black and Arab |
| Lieu de residence | Marseille / Paris / Toulouse / Nice |
| Occupation | Unemployment, freelance or independent work, small businesses or shops, jobs in the transportation sector, jobs in the nightlife sector. |
Users:
| Age | 18 - 34 |
| Nationality | 90% French nationality |
| Sex | 92% males for cannabis 73% males for cocaine |
| Social group | All |
| Ethnicity | Any |
| Lieu de residence | Everywhere |
| Occupation | Any but mainly art, nightlife, restoration sectors |
figure 9: Consumption of drugs by Age
8. Chemical reagents and equipment stores
https://www.servilab.fr/panier
https://www.labomoderne.com/
https://jeulin.com/lelaborantin_fr/
https://www.nadal-alcools.com/produit/bouteille-d-1-litre-dalcool-90-pour-fruits/
https://www.amazon.fr/éthanol/s?k=éthanol
https://www.labs24.net/
https://www.mon-droguiste.com/produit-chimique/liquide
https://www.arcane-direct.com/fr/23-degraissant-par-aspersion
https://chemical.center/fr/les-bases/7-lessive-de-soude-305
9. Drug news
Among young French people there is a great interest in finding out about the evolution of laws regarding flexibility in consumption, especially in relation to marijuana. Some of the portals used to stay up to date are:
• https://discord.gg/sQw7pjW2BK
• https://www.royalqueenseeds.fr/blog
• https://www.zamnesia.fr/blog
• https://www.growbarato.net/blog/
• https://www.sciencesetavenir.fr/
• https://www.cannaconnection.com/fr/blog
• https://www.lefigaro.fr/
• https://www.cbd.fr/blog/
• https://www.huffingtonpost.fr/
• https://lecannabiste.com/
• https://disboard.org/fr/server/join/1015479909054943323
• https://disboard.org/fr/server/join/443788004704649236
• https://www.newsweed.fr/
List of illicit drugs
In France, the substances and preparations mentioned below are classified as narcotic drugs:
Decree of 22 February 1990 laying down the list of substances classified as narcotics
Modified by decree on October 14, 2019
Annex I
- Acetorphine
- Acetylalphamethylfentanyl
- Acetylfentanyl and MT-45 or 1-cyclohexyl-4-(1,2-diphenylethyl) piperazine
- Acetylmethadol
- AH-7921 or 3,4-dichloro-N-[1-(dimethylamino) cyclohexyl] methyl] benzamide
- Alfentanil
- Allylprodine
- Alphacetylmethadol
- Alphameprodine
- Alphamethadol
- Alphamethylfentanyl
- Alphaprodine
- Anileridine
- Benzethidine
- Benzylmorphine
- Beta-hydroxyfentanyl
- Beta-hydroxy-methyl-3-fentanyl
- Betacetylmethadol
- Betameprodine
- Betamethadol
- Betaprodine
- Bezitramide
- Dioxaphetyl butyrate
- Butyrfentanyl or Butyrylfentanyl or N-Phenyl-N-[1-(2-phenylethyl)-4-piperidinyl] butanamide
- Cannabis and cannabis resin
- Ketobemidone
- Clonitazene
- Leaf of coke
- Cocaine
- Codoxime
- Poppy straw concentrate or material obtained when the poppy straw has undergone treatment for the concentration of its alkaloids (capsules, stems)
- Desomorphine
- Dextromoramide
- Diampromide
- Diethylthiambutene
- Diphenoxin
- Dihydroetorphine (13)
- Dihydromorphine
- Dimenoxadol
- Dimepheptanol
- Dimethylthiambutene
- Diphenoxylate, with the exception of oral preparations containing per unit dose, a maximum amount of 2.5 mg calculated in base in combination with an amount of at least 0.025 mg of atropine sulfate
- Dipipanone
- Drotébanol
- Ecgonine, its esters and derivatives that can be converted into ecgonine and cocaine
- Ethylmethylthiambutene
- Etonitazene
- Etorphine
- Etoxetine
- Fentanyl
- Furethidine
- Heroine
- Hydrocodone
- Hydromorphinol
- Hydromorphone
- Hydroxypethidine
- Isomethadone
- Levomethorphan, with the exception of its dextrogyre or dextromethorphane isomer
- Levomoramide
- Levophenacylmorphane
- Levorphanol, with the exception of its dextrogyre or dextrorphane isomer
- Metazocin
- Methadone and its intermediate or cyano-4 dimethylamino-2 diphenyl-4,4 butane
- Methyldesorphine
- Methyldihydromorphine
- Methyl-3-thiofentanyl
- Methyl-3-fentanyl
- Métopon
- Moramide (intermediate with) or methyl-2-morpholino-3 diphenyl-1,1 propane carboxylic acid
- Morpheridine
- Morphine (including opium preparations containing more than 20% expressed as anhydrous base and derivatives pentavalent nitrogen morphines such as methobromide, N-oxymorphin, N-oxycodein), with the exception of ethers named in Annex II and preparations under another classification
- MPPP or methyl-1-phenyl-4 piperidinyl-4 propionate
- Myrophine
- Nicomorphine
- Noracymethadol
- Norlévorphanol
- Normethadone
- Normorphine
- Norpipanone
- Opium (including preparations of opium and papaver somniferum containing up to 20% of calculated morphine in an anhydrous base, with the exception of preparations under another classification)
- Oripavine
- Oxycodone
- Oxymorphone
- Para-fluorofentanyl
- PEPAP or phenyl-1-phenyl-4 piperidinyl-4 acetate
- Pethidine and its intermediates A (cyano-4 methyl-1 phenyl-4 piperidine) B (ethyl ester of phenyl-4-piperidine acid carboxylic-4) and C (methyl-1 phenyl-4-piperidine carboxylic acid-4)
- Phenadoxone
- Phenampromide
- Phenazocin
- Phenomorphane
- Phenoperidin
- Piminodine
- Piritramide
- Proheptazine
- Properidine
- Racemethorphane
- Racemorphan
- Remifentanil, its isomers, esters, ethers and salts in all cases where they may exist
- Sufentanil
- Thebacone
- Thebaïne
- Thiofentanyl
- Tilidine
- Trimeperidine
- U-47700 or 3,4-dichloro-N-[2-(dimethylamino) cyclohexyl]-N-methylbenzamide
- Acryloyl fentanyl
- Carfentanil or carfentanyl
- Furanylfentanyl or N-phenyl-N-[1-(2-phenylethyl) piperidin-4-yl] furan-2-carboxamideocfentanil or ocfentanyl;
- Para-fluoroisobutyr (yl) fentanyl or pFIBF or 4-fluoroisobutyr (yl) fentanyl or 4 FIBF;
- Tetrahydrofuranylfentanyl or THF-F;
- Methoxyacetylfentanyl or 2-methoxy-N-phenyl-N-[1-(2-phenylethyl) piperidin-4-yl] acetamide,
- Cyclopropylfentanyl or (d) N-phenyl-N-[1-(2-phenylethyl) piperidin-4-yl] cyclopropanecarboxamide,
- Parafluorobutyrylfentanyl,
- Orthofluorofentanyl
Annex II
This annex includes:
- the substances below designated;
- their isomers, with express exceptions, in all cases where they may exist, in accordance with the corresponding chemical formula of the said substances;
- the salts of said substances and their isomers in all cases where they may exist;
- their preparations named below;
- Acetyldihydrocodeine
- Codeine
- Dextropropoxyphene and its injectable preparations
- Dihydrocodeine
- Ethylmorphine
- Nicocodine
- Nicodicodine
- Norcodeine
- Pholcodine
Annex III
This annex includes:
- the substances below designated;
- their stereo-isomers, in all cases where they may exist in accordance with the specified chemical designation, for substances preceded by an asterisk;
- their salts in all cases where they may exist;
- the preparations of these substances, with the exception of the one named below;
- AB-CHMINACA or N-[(2S)-1-amino-3-methyl-1-oxobutan-2-yl]-1-(cyclohexylmethyl) indazole-3-carboxamide;
- AB-PINACA or N-[(1S)-1-(aminocarbonyl)-2-methylpropyl]-1-pentyl-1H-indazole-3-carboxamide;
- ADB-CHMINACA or MAB-CHMINACA or N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide;
- 5F-ADB or 5F-MDMB-PINACA or methyl (S)-2-[1-(5-fluoropentyl)-1H-indazole-3-carboxamido]-3,3-dimethylbutanoate;
- ADB-FUBINACA or N-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide;
- 2-CB or 4-bromo-2,5 dimethoxyphenethylamine
- 4-MEC or 4-methylethcathinone or 2-ethylamino-1-(4-methylphenyl)-1-propanone
- 4-MTA or ∀-methyl-4-methylthiophenethylamine
- 4,4'-DMAR or 4,4'-dimethylaminorex or para-methyl-4-methylaminorex, 4,5-dihydro-4-methyl-5-(4-methylphenyl)-2-oxazolamine
- 5F-APINACA or 5F-AKB-48 or N-(adamantan-1-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide)
- α-PVP or alpha-pyrrolidinovalerophenone or 1-phenyl-2-(1-pyrrolidinyl)-1-pentanone, methoxetamine
- Amphetamine, with the exception of the preparation presented in tablets and containing in tablets
- Amphetamine sulfate 0.005 g, phenobarbital 0.100g
- Amineptine
- Benzphetamine, with the exception of its preparations other than injectable
- Brolamfetamin
- Cathinone
- CUMYL-4CN-BINACA or 1-(4-cyanobutyl)-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide;
- DET or N,N-diethyltryptamine
- Dexamfetamin
- DMA or dl-dimethoxy-2,5-methylphenylethylamine
- DMHP or hydroxy-1 (dimethyl-1,2 heptyl)-3 tetrahydro-7,8,9,10 trimethyl-6,6,9 6H-dibenzo(b,d) pyranne
- DMT or N,N-dimethyltryptamine
- DOET or dl-dimethoxy-2,5 ethyl-4-methylphenylethylamine
- Ethylone or bk-MDEA or 3,4-methylenedioxy-N-ethylcathinone (MDEC) or 2-ethylamino-1-(3,4-methylenedioxyphenyl) propane-1-one
- Ethylphenidate or EPH
- Eticyclidine or PCE
- Etilamfetamine
- Etryptamine
- Fenetylline
- 4-Fluoroamphetamine or 4-FA;
- FUB-AMB (MMB-FUBINACA, AMB-FUBINACA) or methyl (2S)-2-{ [1-[(4-fluorophenyl) methyl] indazole-3-carbonyl] amino }-3-methylbutanoate;
- GHB or gamma-hydroxybutyric acid, with the exception of injectable preparations
- Levamfetamine
- Levomethamphetamine
- Lysergide or LSD-25
- MDMA or dl N, -dimethyl (methylenedioxy)-3,4 phenylethylamine
- MDMB-CHMICA or MMB-CHMINACA or methyl (2S)-2-{ [1-(cyclohexylmethyl)-1H-indol-3-yl] formamido }-3,3-dimethylbutanoate
- Mécloqualone
- Mescaline
- MMDA or methoxy-2-methyl (methylenedioxy)-4,5 phenylethylamine
- Mefenorex and its salts, with the exception of preparations other than injectable
- Methamphetamine and its racemate
- Methaqualone
- Methiopropamine or MPA or 1-(alpha-thiényl)-2-methylaminopropane
- Methylphenidate
- Methyl-4 aminorex
- N-hydroxytenamfetamine
- N-ethyltenamphetamine (MDEA)
- N-ETHYLNORPENTYLONE (Ephylone)
- Parahexyl
- 5F-PB-22 or 5F-QUPIC or 1-pentyfluoro-1H-indole-3-carboxylic acid 8-quinolinyl ester;
- Pentazocine
- Pentedrone or alpha-methylamino-valerophenone or 2-(methylamino)-1-phenyl-1-pentan-1-one
- Phencyclidine
- Phendimetrazine
- Phenmetrazine
- Phentermine or α, α-dimethylphenetylamine
- PMA or p-methoxy-methylphenylethylamine
- PMMA or para-methoxymethamphetamine or para-methoxymethylamphetamine
- Psilocine
- Psilocybin
- Rolicyclidine or PHP or PCPY
- Secobarbital
- STP or DOM or amino-2(dimethoxy-2,5-methyl-4)phenyl-1 propane
- Tenamfetamin or MDA
- Tenocyclidine or TCP
- TMA or dl-trimethoxy-3,4,5-methylphenylethylamine
- UR-144 or (1-pentylindol-3-yl)-(2,2,3,3-tetramethylcyclopropyl) methanone;
- XLR-11 or 5F-UR-144 or (1-(5-fluoropentyl)-1H-indol-3-yl) (2,2,3,3-tetramethylcyclopropyl) methanone
- Zipeprol
- 25B-NBOMe or 2C-B-NBOMe or 2-(4-bromo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine or 4-Bromo-2,5-dimethoxy-N-(2- methoxybenzyl)phenethylamine
- 25C-NBOMe or 2C-C-NBOMe or 2-(4-chloro-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine or 4-Chloro-2,5-dimethoxy-N-(2-methoxybenzyl)phenethylamine
- 25I-NBOMe or 2C-I-NBOMe or 4-iodo-2,5-dimethoxy-N-(2-methoxybenzyl)phenethylamine
Annex IV
This annex includes the following designated products and their preparations:
- 2-CI
- 2-CT-2 or 2,5-dimethoxy-4-ethylthiophenylethylamine
- 2-CT-7 or 2,5-dimethoxy-4-
-propyl-thiophenylethylamine - Lysergic acid, its halogenated derivatives, and their salts
- Amfépentorex and its salts, with the exception of their preparations other than injectable
- Ayahusca Banisteteriopis caapi, Peganum harmala, Psychotria viridis, Diplopterys cabrerana, Mimosa hostilis,
- Banisteriopsis rusbyana, harmine, harmaline, tetrahydroharmine (THH), harmol, harmalol,
- Beta hydroxy alpha, beta-diphenylethylamine, its isomers, esters, ethers and their salts
- BZP or benzylpiperazine
- 5F-AB-FUPPYCA (or AZ-037) or N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(5-fluoropentyl)-5-(4-fluorophenyl)-1H-pyrazole-3-carboxamide;
- A-836,339 or N-[3-(2-methoxyethyl)-4,5-dimethyl-1,3-thiazol-2-ylidene]-2,3,3-tetramethylcyclopropane-1-carboxamide;
- AB-CHFUPYCA (or AB-CHMFUPPYCA) or N-[3-(2-methoxyethyl)-4,5-dimethyl-1,3-thiazol-2-ylidene]-2,3,3-tetramethylcyclopropane-1-carboxamide;
- ADSB-FUB-187 or 7-chloro-N-[(2S)-1-[2-(cyclopropylsulfonylamino) ethylamino]-3,3-dimethyl-1-oxobutan-2-yl]-1-[(4-fluorophenyl) methyl] indazole-3-carboxamide;
- CB-13 (or CRA-13 or SAB-378) or naphthalene-1-yl-(4-pentyloxynaphthalen-1-yl) methanone;
- EG-018 naphthalene-1-yl (9-pentyl-9H-carbazol-3-yl) methanone;
- HU-210 or (6aR, 10aR)-9-(hydroxymethyl)-6,6-dimethyl-3-(2-methyloctan-2-yl)-6a, 7,10, 10a-tetrahydrobenzo [c] chromen-1-ol;
- HU-243 or (6aR, 9R, 10aR)-9-(hydroxymethyl)-6,6-dimethyl-3-(2-methyloctan-2-yl)-6a, 7,8,9,10, 10a-hexahydrobenzo [c] chromen-1-ol;
- FUBIMINA (or BIM-2201 or BZ-2201 or FTHJ) or 1-(5-fluoropentyl)-1H-benzo [d] imidazol-2-yl) (naphthalen-1-yl) methanone;
- JTE-7-31 or 2-[2-(4-hydroxyphenyl) ethyl]-5-methoxy-4-(pentylamino)-2,3-dihydro-1H-isoindol-1-one;
- WIN 55,212-2 or (R)-(+)-[2,3-Dihydro-5-methyl-3-(4-morpholinylmethyl) pyrrolo [1,2,3-de]-1,4-benzoxazin-6-yl]-1-napthalenylmethanone.
- Indol-3-yl methanone
- with a grouping (otherwise substituted or not), on the carbon of the methane bridge of the type naphthyl, benzyl, phenyl, cyclopropyl, adamantyl.
In particular:
- JWH-007 or 1-pentyl-2-methyl-3-(1-naphthoyl) indole;
- JWH-015 or (2-methyl-1-propylindol-3-yl)-naphthalene-1-ylmethanone or 1-propyl-2-methyl-3-(1-naphthoyl) indole;
- JWH-018 or 1-pentyl-3-(1-naphthoyl) indole or 2- naphthalenyl (1- pentyl- 1H- indol- 3- yl)- methane;
- JWH-019 or (1-hexyl-1H-indol-3-yl)-1-naphthalenylmethanone or 1-hexyl-3-(1-naphthoyl) indole;
- JWH-073 or (1-butyl-1H-indol-3-yl) (naphthalen-1-yl) methanone or 1-butyl-3-(1-napthoyl) indole;
- JWH-081 or (4-methoxynaphthalen-1-yl) (1-pentyl-1H-indol-3-yl) methanone or 1-pentyl-3-(4-methoxy-1-naphthoyl) indole;
- JWH-122 or (4- methyl- 1- naphthalenyl) (1- pentyl- 1H- indol- 3- yl)- methanone or 1-pentyl-3-(4-methyl-1-naphthoyl) indole;
- JWH-182 or (1- pentyl- 1H- indol- 3- yl) (4- propyl- 1- naphthalenyl)- methane;
- JWH-200 or [1- [2- (4- morpholinyl) ethyl]- 1H- indol- 3- yl]- 1- naphthalenyl- methanone or 1-[2-(4-morpholinyl) ethyl]-3-(1-naphthoyl) indole;
- JWH-203 or 1-pentyl-3-(2-chlorophenylacetyl) indole;
- JWH-210 or (4- ethyl- 1- naphthalenyl) (1- pentyl- 1H- indol- 3- yl)- methanone or 1-pentyl-3-(4-ethyl-1-naphthoyl) indole;
- JWH-387 or (4- bromo- 1- naphthalenyl) (1- pentyl- 1H- indol- 3- yl)- methanone;
- JWH-398 or 1-pentyl-3-(4-chloro-1-naphthoyl) indole;
- JWH-412 or (4- fluoro- 1- naphthalenyl) (1- pentyl- 1H- indol- 3- yl)- methanone;
- AM-2201 or (1- (5- fluoropentyl)- 1H- benzo [d] imidazol- 2- yl) (naphthalene- 1- yl) methanone or 1-(5-fluoropentyl)-3-(1-naphthoyl) indole;
- MAM-2201 or [1-(5-fluoropentyl)-1H-indol-3-yl]-1-naphthalenyl-methanone;
- FUB-JWH-018 or (1-(4-fluorobenzyl)-1H-indol-3-yl) (naphthalen-1-yl) methanone;
- JWH-167 or 1- (1- pentyl- 1H- indol- 3- yl)- 2- phenyl- ethanone;
- JWH-201 or 2-(4-methoxyphenyl)-1-(1-pentylindol-3-yl) ethanone;
- JWH-250 or 1-pentyl-3-(2-methoxyphenylacetyl) indol or 1- (1- pentyl- 1H- indol- 3- yl)- 2- (2- methoxyphenyl)- ethanone;
- JWH-251 or 1-pentyl-3-(2-methylphenylacetyl) indole or 2- (2-methylphenyl)- 1- (1- pentyl- 1H- indol- 3- yl)- ethanone;
- RCS-4 or 1-pentyl-3-(4-methoxybenzoyl) indole;
- AM-694 or 1-(5-fluoropentyl)-3-(2-iodobenzoyl) indole or [1- (5- fluoropentyl)- 1H- indol- 3- yl] (2- iodophenyl)- methane;
- AM-679 or (2-iodophenyl) (1-pentyl- 1H-indol-3-yl)- methanone;
- AM-2233 or (2- iodophenyl) [1- (1-methyl- 2-piperidinyl) methyl]-1H-indol- 3-yl]-methanone;
- 5Cl-UR-144 or [1-(5-chloropentyl)-1H-indol-3-yl] (2,2,3,3-tetramethylcyclopropyl) methanone;
- AB-005 or [1-[(1-methyl-2-piperidinyl) methyl]-1H-indol-3-yl] (2,2,3,3-tetramethylcyclopropyl)-methanone;
- A-834,735 or { 1-[(tetrahydro-2H-pyran-4-yl) methyl]-1H-indol-3-yl }-(2,2,3,3-tetramethylcyclopropyl) methanone;
- AB-001 or (1-pentyl-3-(adamant-1-oyl) indole);
- AM-1220 or (1-((1-methyl-2-piperidinyl) methyl)-1H-indol-3-yl)-1-naphthalenylmethanone;
- AM-1248 or (1-[(N-methylpiperidin-2-yl) methyl]-3-(adamant-1-oyl) indole).
- Indazol-3-yl methanone
- with a substitute on nitrogen in position 1 of the indazole nucleus of the alkyl, haloalkyl, halobenzyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, methyl-oxane, 1-(N-methylpiperidin-2-yl) methyl or 2-(4-morpholinyl) ethyl type;
- with a grouping (otherwise substituted or not), on the carbon of the methane bridge of the type naphthyl, benzyl, phenyl, cyclopropyl, adamantyl.
In particular:
- THJ-018 or 1-naphthalenyl (1-pentyl-1H-indazol-3-yl)-methanone;
- THJ-2201 or [1-(5-Fluoropentyl)-1H-indazol-3-yl] (1-naphthyl) methanone.
- with a substitute on the nitrogen of the pyrrole nucleus such as alkyl, haloalkyl, halobenzyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, methyl-oxane, or 2-(4-morpholinyl) ethyl;
- that the pyrrole nucleus is otherwise substituted or not;
- whoether the naphthyl nucleus is otherwise substituted or not.
In particular:
- JWH-030 or 1-naphthalenyl (1-pentyl-1H-pyrrol-3-yl)-methanone;
- JWH-145 or 1-naphthalenyl (1-pentyl-5-phenyl-1H-pyrrol-3-yl)-methanone;
- JWH-146 or (1-heptyl-5-phenyl-1H-pyrrol-3-yl)-1-naphthalenyl-methanone;
- JWH-147 or (1-hexyl-5-phenyl-1H-pyrrol-3-yl)-1-naphthalenyl-methanone;
- JWH-307 or (5-(2-fluorophenyl)-1-pentylpyrrol-3-yl)-naphthalene-1-yl-methanone;
- JWH-368 or [5- (3- fluorophenyl)- 1- pentyl- 1H- pyrrol- 3- yl]- 1- naphthalenyl- methanone;
- JWH-370 or [5-(2-methylphenyl)-1-pentyl-1H-pyrrol-3-yl]-1-naphthalenyl-methanone.
- Naphthylmethylindols or indol-3-yl-(1-naphthyl) methane derivatives
- with a substitute on the nitrogen of the indole nucleus such as alkyl, haloalkyl, halobenzyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, methyl-oxane, 1-(N-methylpiperidin-2-yl) methyl or 2-(4-morpholinyl) ethyl;
- whoever the indole nucleus is otherwise substituted or not;
- whoether the naphthyl nucleus is otherwise substituted or not.
In particular:
- JWH-175 or 3- (1- naphthalenylmethyl)- 1- pentyl- 1H- indole or 1-pentyl-1H-indol-3-yl-(1-naphthyl) methane;
- JWH-184 or 3-[(4-methyl-1-naphthalenyl) methyl]-1-pentyl-1H-indole or 1-pentyl-1H-3-yl-(4-methyl-1-naphthyl) methane;
- JWH-185 or 3-[(4-methoxy-1-naphthalenyl) methyl]-1-pentyl-1H-indole.
- with a substitute in position 3 of the indene nucleus such as alkyl, haloalkyl, halobenzyl, alkenyl, cycloalkylmethyl, methyl-oxane, cycloalkylethyl, 1-(N-methylpiperidin-2-yl) methyl or 2-(4-morpholinyl) ethyl;
- whoever the indene nucleus is otherwise substituted or not;
- whoether the naphthyl nucleus is otherwise substituted or not.
In particular:
- JWH-176 or 1-([(1E)-3-pentylinden-1-ylidine] methyl) naphthalene.
- Cyclohexylphenols or derivatives of 2-(3-hydroxycyclohexyl) phenol
- with a substitute in position 5 of the phenol nucleus type alkyl, haloalkyl, halobenzyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, methyl-oxane, 1-(N-methylpiperidin-2-yl) methyl or 2-(4-morpholinyl) ethyl;
- whoever the cyclohexyl core is otherwise substituted or not.
In particular:
- CP 55,940 or 5-(1,1-dimethylheptyl)-2-[(1R, 2R)-5-hydroxy-2-(3-hydroxypropyl) cyclohexyl]-phenol or 2- ((1S, 2S, 5S)- 5- hydroxy- 2- (3- hydroxypropyl) cyclohexyl)- 5- (2- methyloctane- 2- yl) phenol;
- CP 47,497 or (5-(1,1-dimethylheptyl)-2-[(1R, 3S)-3-hydroxycyclohexyl]-phenol;
- CP 47,497-C6 or (5-(1,1-dimethylhexyl)-2-[(1R, 3S)-3-hydroxycyclohexyl]-phenol;
- CP 47,497-C8 or (5-(1,1-dimethyloctyl)-2-[(1R, 3S)-3-hydroxycyclohexyl]-phenol;
- CP 47,497-C9 or (5-(1,1-dimethylnonyl)-2-[(1R, 3S)-3-hydroxycyclohexyl]-phenol.
- with a substitute on the nitrogen of the indol nucleus such as alkyl, haloalkyl, halobenzyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, methyl-oxane, 1-(N-methylpiperidin-2-yl) methyl or 2-(4-morpholinyl) ethyl;
- whoever the indole nucleus is otherwise substituted or not;
- with a grouping (otherwise substituted or not), on the oxygen of the carboxylate bridge of the 8-quinolinyl or 1-naphthalenyl type.
In particular:
- PB-22 or QUPIC or 1-pentyl-1H-indole-3-carboxylic acid 8-quinolinyl ester;
- BB-22 or QUCHIC or 1-(cyclohexylmethyl)-1H-indole-3-carboxylic acid 8-quinolinyl ester;
- FUB-PB-22 or quinoline-8-yl 1-[(4-fluorophenyl) methyl]-1H-indole-3-carboxylate);
- FDU-PB-22 or naphthalene-1-yl 1-[(4-fluorophenyl) methyl]-1H-indole-3-carboxylate;
- NM-2201 or CBL-2201 or naphthalene-1-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate.
- with a substitute on nitrogen in position 1 of the indazole nucleus such as alkyl, haloalkyl, halobenzyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, methyl-oxane, 1-(N-methylpiperidin-2-yl) methyl or 2-(4-morpholinyl) ethyl;
- whether the indazole nucleus is otherwise substituted or not;
- with a grouping (otherwise substituted or not), on the oxygen of the carboxylate bridge of the 8-quinolinyl or 1-naphthalenyl type.
In particular:
- NPB-22 or 1-pentyl-1H-indazole-3-carboxylic acid, 8-quinolinyl ester;
- 5F-NPB-22 or 1-(5-fluoropentyl)-8-quinolinyl ester-1H-indazole-3-carboxylic acid;
- FUB-NPB-22 or quinoline-8-yl 1-(4-fluorobenzyl)-1H-indazole-3-carboxylate;
- SDB-005 or naphthalene-1-yl 1-pentyl-1H-indazole-3-carboxylate;
- 5F-SDB-005 or 1-(5-Fluoro-pentyl)-1H-indazole-3-carboxylic acid naphthalen-1-yl ester.
- with a substitute on the nitrogen of the indol nucleus such as alkyl, haloalkyl, halobenzyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, methyl-oxane, 1-(N-methylpiperidin-2-yl) methyl or 2-(4-morpholinyl) ethyl;
- whoever the indole nucleus is otherwise substituted or not;
- with the nitrogen of the carboxamide bridge integrated into a cycle or carrying a substitute of the cumyl, naphthyl, adamantanyl, benzyl, bicyclo [2.2.1] heptanyl type, or carrying a group of type 1-alkoxy-1-oxo-butan-2-yl, 1-amino-1-oxo-butan-2-yl, whether or not this group is itself substituted in position 3 by one or two alkyl, cycloalkyl or phenyl type substitutes.
In particular:
- CUMYL-BICA or 5F-CUMYL-PINACA or SGT-25 or 1-(5-fluoropentyl)-N-(1-methyl-1-phenylethyl)-1H-indazole-3-carboxamide);
- CUMYL-PICA or 1-pentyl-N-(2-phenylpropan-2-yl)-1H-indole-3-carboxamide;
- CUMYL-5F-PICA or 1-(5-Fluoropentyl)-N-(2-phenylpropan-2-yl)-1H-indole-3-carboxamide;
- NNE1 or MN-24 or NNEI or AM-6527 or N-1-naphthalenyl-1-pentyl-1H-indole-3-carboxamide;
- 5F-MN-24 or 5F-NNEI or 1-(5-Fluoropentyl)-N-(1-naphthyl) indole-3-carboxamide;
- MN-25 or UR-12 or 7-methoxy-1-(2-morpholin-4-ylethyl)-N-[(1R, 3S, 4S)-2,2,4-trimethyl-3-bicyclo [2.2.1] heptanyl] indole-3-carboxamide;
- SDB-001 or APICA or 2NE1 or N-(1-adamantyl)-1-pentylindole-3-carboxamide;
- STS-135 or 5F-APICA or N-(Adamantan-1-yl)-1-(5-fluoropentyl)-1H-indole-3-carboxamide;
- SDB-006 or N-benzyl-1-pentyl-1H-indole-3-carboxamide;
- PX-1 or 5F-APP-PICA or SRF-30 or (S)-N-(1-amino-1-oxo-3-phenylpropan-2-yl)-1-(5-fluoropentyl)-1H-indole-3-carboxamide;
- 5F-AMP or (N-(cyclopropylmethyl)-1-(5-fluoropentyl)-1H-indole-3-carboxamide;
- 5F-PY-PICA 1-(5-fluoropentyl)-3-(pyrrolidine-1-carbonyl)-1H-indole;
- MEPIRAPIM or (4-methylpiperazin-1-yl) (1-pentyl-1H-indol-3-yl) methanone;
- MMB-CHMICA or AMB-CHMICA or methyl N-[1-(cyclohexylmethyl)-1H-indole-3-carbonyl) valinate;
- 5F-MDMB-PICA or N-[[1-(5-fluoropentyl)-1H-indol-3-yl] carbonyl]-3-methyl-L-valine, methyl ester.
- with a substitute on nitrogen in position 1 of the indazole nucleus such as alkyl, haloalkyl, halobenzyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, methyl-oxane, 1-(N-methylpiperidin-2-yl) methyl or 2-(4-morpholinyl) ethyl;
- whether the indazole nucleus is otherwise substituted or not;
- with the nitrogen of the carboxamide bridge integrated into a cycle or carrying a substitute of the cumyl, naphthyl, adamantanyl, benzyl, bicyclo [2.2.1] heptanyl type, or carrying a group of type 1-alkoxy-1-oxo-butan-2-yl, 1-amino-1-oxo-butan-2-yl, whether or not this group is itself substituted in position 3 by one or two alkyl, cycloalkyl or phenyl type substitutes.
In particular:
- AB-FUBINACA or N-[(1S)-1-(aminocarbonyl)-2-methylpropyl]-1-[(2-fluorophenyl) methyl]-1H-indazole-3-carboxamide;
- 5F-AB-PINACA or N-[(2S)-1-amino-3-methyl-1-oxobutan-2-yl]-1-(5-fluoropentyl) indazole-3-carboxamide;
- MDMB-FUBINACA or MDMB (N)-Bz-F or FUB-MDMB or methyl (2S)-2-{ [1-[(4-fluorophenyl) methyl] indazole-3-carbonyl] amino }-3,3-dimethylbutanoate;
- ADB-PINACA or N-(1-Amino-3,3-dimethyl-1-oxo-2-butanyl)-1-pentyl-1H-indazole-3-carboxamide;
- 5F-ADB-PINACA or N-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide;
- 5F-AMB or 5F-MMB-PINACA or 5F-AMB-PINACA or methyl (2S)-2-{ [1-(5-fluoropentyl) indazole-3-carbonyl] amino }-3-methylbutanoate;
- 5C-AKB-48 or N-(adamantan-1-yl)-1-(5-chloropentyl)-1H-indazole-3-carboxamide:
- APINACA or AKB-48 or N-(1-adamantyl)-1-pentylindazole-3-carboxamide);
- FUB-APINACA or FUB-AKB-48 or N-(adamantan-1-yl)-1-[(4-fluorophenyl) methyl]-1H-indazole-3-carboxamide;
- 5F-APP-PINACA or FU-PX or PX-2 or PPA (N)-2201 or (R)-N-(1-amino-1-oxo-3-phenylpropan-2-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide;
- CUMYL-PINACA or SGT-24 or 1-pentyl-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide;
- 5F-CUMYL-PINACA or SGT-25 or C-Liquid or 1-(5-fluoropentyl)-N-(1-methyl-1-phenylethyl)-1H-indazole-3-carboxamide;
- CUMYL-THPINACA or SGT-42 or 1-(oxan-4-ylmethyl)-N-(2-phenylpropan-2-yl) indazole-3-carboxamide;
- MN-18 or N-(naphthalene-1-yl)-1-pentyl-1H-indazole-3-carboxamide;
- 5F-MN18 or 1- (5- fluoropentyl)- N- 1- naphthalenyl- 1H- indazole- 3- carboxamide.
- with a substitute on nitrogen in position 1 of the pyrrolo [3,2-c] pyridine nucleus such as alkyl, haloalkyl, halobenzyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, methyl-oxane, 1-(N-methylpiperidin-2-yl) methyl or 2-(4-morpholinyl) ethyl;
- whether the pyrrolo [3,2-c] pyridine nucleus is otherwise substituted or not;
- with a substitute on the nitrogen of the naphthyl-type carboxamide bridge, substituted or not.
In particular:
- 5F-PCN or 5F-MN-21 or 1-(5-fluoropentyl)-N-(naphthalen-1-yl)-1H-pyrrolo [3,2-c] pyridine-3-carboxamide.
- with a substitute on the nitrogen of the indol nucleus such as alkyl, haloalkyl, halobenzyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, methyl-oxane, 1-(N-methylpiperidin-2-yl) methyl or 2-(4-morpholinyl) ethyl;
- whoever the indole nucleus is otherwise substituted or not;
- whoever the thiazole nucleus is otherwise substituted or not.
In particular:
- PTI-1 or N, N-diethyl-N-((2-(1-pentyl-1H-indol-3-yl) thiazol-4-yl) methyl) ethanamine;
- PTI-2 or N-(2-methoxyethyl)-N-((2-(1-pentyl-1H-indol-3-yl) thiazol-4-yl) methyl) propane-2-amine.
- Hallucogenic fungi, including the genera stropharia, conocybes and psilocybe
- Chlorphentermine and its salts, with the exception of their preparations other than injectable
- Fenbutrazate and its salts
- ketamine, as well as its salts and stereoisomers
- Khat (leaves of Catha edulis, Celastracées)
- Levophacetoperane and its salts
- Lisdexamphetamine and its salts
- MBDB or N-methyl-1-(3,4-methylenedioxyphenyl)-2-butanamine and its salts in all cases where they may exist
- a substituent alkyl, phenyl, alkoxy, alkylenedioxy, haloalkyl, halogenated on the phenyl cycle;
- an alkyl substituent in position 3;
- an alkyl or dialkyl or cyclic substituent on nitrogen; with the exception of bupropion.
Any structure derived from 2-amino-1-one propane by substitution in position 1 with any monocyclic or polycyclic system, as well as its salts and stereoisomers.
In particular:
- amfepramone or diethylpropion or 2-diethylamino-1-phenylpropan-1-one;
- benzedrone or 4-MBC or methylbenzylcathinone or 1-(4-methylphenyl)-2-benzylaminopropan-1-one;
- BMDB or 2-benzylamino-1-(3,4-methylenedioxyphenyl) butane-1-one;
- BMDP or 3,4-MDBC or 2-benzylamino-1-(3,4-methylenedioxyphenyl) propane-1-one;
- brephedrone or 4-bromomethcathinone or 4-BMC or 1-(4-bromophenyl)-2-methylaminopropan-1-one;
- buphedrone or 2-(methylamino)-1-phenylbutan-1-one;
- butylone or bk-MBDB or 2-methylamino-1-(3,4-methylenedioxyphenyl) butan-1-one;
- dibutylone or methylbutylone or bk-MBDB or 2-dimethylamino-1-(3,4-methylenedioxyphenyl) butan-1-one;
- dimethylone or bk-MDDMA or 1-(1,3-benzodioxol-5-yl)-2-(dimethylamino) propane-1-one;
- 3,4-DMMC or 1-(3,4-dimethylphenyl)-2-(methylamino) propane-1-one;
- 4-EMC or 4-ethylmethcathinone or 2-methylamino-1-(4-ethylphenyl) propane-1-one;
- ethylcathinone or ethylpropion or 2-ethylamino-1-phenyl-propane-1-one;
- 4-ethylmethcathinone or 4-EMC or 2-methylamino-1-(4-ethylphenyl) propane-1-one;
- phlephedrone or 4-FMC or 4-fluoromethcathinone or 2-methylamino-1-p-fluorophenyl-propan-1-one;
- 3-FMC or 3-fluoromethcathinone or 2-methylamino-1-(3-fluorophenyl) propane-1-one;
- iso-ethcathinone or 1-ethylamino-1-phenyl-propane-2-one;
- iso-pentedrone or 1-methylamino-1-phenyl-pentan-2-one;
- MDMPP or 1-(3,4-methylenedioxyphenyl)-2-methyl-2-pyrrolidinyl-1-propanone;
- MDBPP or 1-(3,4-methylenedioxyphenyl)-2-(1-pyrrolidinyl)-1-butanone;
- MDPPP or 1-(3,4-methylenedioxyphenyl)-2-(1-pyrrolidinyl)-1-propanone;
- MDPV or MDPK or 1-(3,4-methylenedioxyphenol)-2-pyrrolidinyl-pentan-1-one;
- mephedrone or 4-MMC or methylmethcathinone or 2-ethylamino-1-(4-methylphenyl) propane;
- metamfepramone or dimethylcathinone or dimethylpropion or 2-dimethylamino-1-phenylpropan-1-one;
- methcathinone or ephedrone or 2-(methylamino)-1-phenyl-propane-1-one;
- methedrone or PMMC or 4-methoxymethcathinone or bk-PMMA or 1-(4-methoxyphenyl)-2-(methylamino) propane-1-one;
- 4-methylbuphedrone or 4-Me-MABP or bk-N-methyl-4-MAB or 2-(methylamino)-1-(4-methylphenyl) butan-1-one;
- methylone or MDMCAT or bk-MDMA or 2-methylamino-1-[3,4-methylenedioxyphenyl] propane-1-one;
- MOPPP or 4'-methoxy-alpha-pyrrolidinopropiophenone;
- MPBP or 1-(4-methylphenyl)-2-(1-pyrrolidinyl)-1-butanone;
- MPHP or 4'-methyl-alpha-pyrrolidinohexanophenone;
- MPPP or 4'-methyl-alpha-pyrrolidinopropiophenone;
- naphyrone or naphthylpyrovalerone or 1-naphthalene-2-yl-2-pyrrolidin-1-ylpentan-1-one;
- 1-naphyrone or 1-naphthalene-1-yl-2-pyrrolidine-1-ylpentan-1-one;
- N-ethyl buphedrone or NEB or 2-ethylamino-1-phenylbutan-1-one;
- pentylone or bk-MBDB or 2-methylamino-1-(3,4-methylenedioxyphenyl) pentan-1-one;
- PPP or 1-Phenyl-2-(1-pyrrolidinyl)-1-propanone;
- Pyrovalerone or 1-(4-methylphenyl)-2-(1-pyrrolidinyl) pentan-1-one.
- Nabilone and its salts in all cases where they may exist
- Pentorex and its salts, with the exception of their preparations other than injectable
- Peyotl or peyote, its active ingredients and their natural and synthetic compounds other than mescaline
- Phenylacetone or phenyl-1 propanone-2
- Tabernanthe iboga, Tabernanthe manii, ibogain, its isomers, esters, ethers and their salts whether of natural or synthetic origin as well as all preparations containing them
- Tapentadol and its salts
- Tetrahydrocannabinols, their esters, ethers, salts as well as the salts of the aforementioned derivatives
- Tiletamine and its salts, with the exception of their injectable preparations
- TMA-2 or 2,4,5-trimethoxyamphetamine
- 4-methylamphetamine
- 5-IT or 5-(2-aminopropyl) indole
- substituted on the phenyl cycle in any way;
and
- substituted on the amine group by at least one benzyl group, with an alkoxy, alkylenedioxy, halogenated or hydroxy substituent on the phenyl cycle.
In particular:
- 25D-NBOMe or 2C-D-NBOMe or 2-(2,5-dimethoxy-4-methylphenyl)-N-(2-methoxybenzyl)ethanamine;
- 25E-NBOMe or 2C-E-NBOMe or 2-(2,5-dimethoxy4-ethylphenyl)-N-(2-methoxybenzyl)ethanamine;
- 25G-NBOMe or 2C-G-NBOMe or 2-(2,5-dimethoxy-3,4-dimethylphenyl)-N-(2-methoxybenzyl)ethanamine;
- 25H-NBOMe or 2C-H-NBOMe or 2-(2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine or 2,5-dimethoxy-N-(2-methoxybenzyl)phenethylamine;
- 25N-NBOMe or 2C-N-NBOMe or 2-(2,5-dimethoxy-4-nitrophenyl)-N-(2-methoxybenzyl)ethanamine;
- 25iP-NBOMe or 2C-iP-NBOMe or 2-[2,5-dimethoxy-4-(propane-2-yl)phenyl]-N-(2-methoxybenzyl)ethanamine;
- 25I-NBMD or cimbi-29 or 2-(4-iodo-2,5-dimethoxyphenyl)-N-[(2,3-methylenedioxyphenyl)methyl]ethanamine;
- 25I-NB34MD or 2-(4-iodo-2,5-dimethoxyphenyl)-N-[(3,4-methylenedioxyphenyl)methyl]ethanamine;
- 25I-NBF or cimbi-21 or 2-(4-iodo-2,5-dimethoxyphenyl)-N-[(2-fluorophenyl)methyl]ethanamine;
- 25I-NBOH or cimbi-27 or 2-((4-iodo-2,5-dimethoxyphenethyl)amino)methyl)phenol;
- 30C-NBOMe or C30-NBOMe or 2-(4-chloro-2,5-dimethoxyphenyl)-N-(3,4,5-trimethoxybenzyl)ethanamine;
- 4-EA-NBOMe or 4-ethylamphetamine-NBOMe;
- 4-MMA-NBOMe or 4-methylmethamphetamine-NBOMe or N-[(2-methoxyphenyl)methyl]-N-methyl-1-(p-tolyl)propane-2-amine;
- 3,4-DMA-NBOMe or 3,4-dimethoxyamphetamine-NBOMe or 1-(3,4-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]propan-2-amine;
- 5-APB-NBOMe or 1-(benzofuran-5-yl)-N-[(2-methoxyphenyl)methyl]propan-2-amine).
- RH-34 or 3-[2-(2-methoxybenzylamino)ethyl]-1H-quinazoline-2,4-dione - 3-fluorofentanyl;
- 4-methoxybutyr (yl) fentanyl;
- beta-hydroxythiofentanyl;
- despropionylfentanyl;
- despropionyl-2-fluorofentanyl;
- isobutyr (yl) fentanyl;
- methoxyacetylfentanyl;
- para-chloroisobutyrfentanyl or 4-chloroisobutyrfentanyl;
- tetrahydrofuranylfentanyl or THF-F;
- valerylfentanyl;
- Diphenidine or 1-(1,2-diphenylethyl) piperidine or 1,2-DEP or DPD or DND;
- Ephenidine or N-ethyl-1,2-diphenylethylamine or NEDPA or EPE;
- Methoxphenidine or methoxyphenidine or 1-[1-(2-methoxyphenyl)-2-phenylethyl] piperidine or
- 2-MeO-diphenidine or methoxydiphenidine or MXP.
- 2C-C or 2,5-dimethoxy-4-chlorophenethylamine or 1-(4-chloro-2,5-dimethoxyphenyl)-2-ethanamine;
- 2C-D or 2C-M or 2,5-dimethoxy-4-methylphenethylamine or 1-(4-methyl-2,5-dimethoxyphenyl)-2-ethanamine;
- 2C-E or 2,5-dimethoxy-4-ethylphenethylamine or 1-(4-ethyl-2,5-dimethoxyphenyl)-2-ethanamine;
- 2C-P or 2,5-dimethoxy-4-propylphenethylamine or 1-(4-propyl-2,5-dimethoxyphenyl)-2-ethanamine;
- 2C-T-4 or 2,5-dimethoxy-4-isopropylthiophenethylamine or 2-[4-(isopropylthio)-2,5-dimethoxyphenyl] ethanamine;
- 2C-T-21 or 2,5-dimethoxy-4-fluoroethylthiophenethylamine or 2-[2,5-dimethoxy-4-(2-fluoroethylthio) phenyl] ethanamine;
- bk-2C-B or beta-keto-2C-B or 2-amino-1-(4-bromo-2,5-dimethoxyphenyl) ethanone;
- substituted by an alpha ethylamine group regardless of its position on the benzofuran nucleus, whether or not the ethylamine function is itself substituted on nitrogen by one or more alkyl groups and/or substituted or not in the alpha position by an alkyl group;
- substituted or not otherwise by an alkoxy group.
In particular:
- 5-APB or 5-(2-aminopropyl) benzofuran;
- 6-APB or 6-(2-aminopropyl) benzofuran;
- 5-EAPB or 5-(2-ethylaminopropyl) benzofuran or 1-(1-benzofuran-5-yl)-N-ethylpropan-2-amine;
- 6-EAPB or 6-(2-ethylaminopropyl) benzofuran or 1-(1-benzofuran-6-yl)-N-ethylpropan-2-amine;
- 5-MAPB or 5-(N-methyl-2-aminopropyl) benzofuran or (1-(benzofuran-5-yl)-N-methylpropan-2-amine);
- 6-MAPB or 6-(N-methyl-2-aminopropyl) benzofuran or (1-(benzofuran-6-yl)-N-methylpropan-2-amine);
- 5-MBPB or 5-MABB or 1-(1-benzofuran-5-yl)-N-methylbutan-2-amine;
- 5-MeO-DiBF or 5-methoxy-N, N-diisopropylbenzofuranethylamine or N-[2-(5-methoxy-1-benzofuran-3-yl) ethyl]-N-(propan-2-yl) propan-2-amine.
Any molecule derived from the 2,3-dihydrobenzofuran nucleus:
- substituted by an alpha ethylamine group regardless of its position on the 2,3-dihydrobenzofuran nucleus, whether or not the ethylamine function is itself substituted on nitrogen by one or more alkyl groups and/or substituted or not in alpha position by an alkyl group;
- substituted or not otherwise by an alkoxy group.
In particular:
- 5-APDB or 3-desoxy-MDA or 5-(2-aminopropyl)-2,3-dihydrobenzofuran or 1-(2,3-dihydro-1-benzofuran-5-yl) propane-2-amine;
- 6-APDB or 4-desoxy-MDA or 6-(2-aminopropyl)-2,3-dihydrobenzofuran or 1-(2,3-dihydro-1-benzofuran-6-yl) propane-2-amine;
- 5-MAPDB or 1-(2,3-dihydrobenzofuran-5-yl)-N-methylpropan-2-amine or 1-(2,3-dihydrobenzofuran-5-yl)-N-methylpropan-2-amine;
- 6-MAPDB or 1-(2,3-dihydrobenzofuran-6-yl)-N-methylpropan-2-amine or 1-(2,3-dihydro-1-benzofuran-6-yl)-N-methylpropan-2-amine;
- 3.4-dichloromethylphenidate (3.4-CTMP) and its salts;
- 4-fluoroethylphenidate and its salts;
- 4-fluoromethylphenidate and its salts;
- 4-methylmethylphenidate and its salts;
- isopropylphenidate and its salts;
- propylphenidate (PPH) and its salts.
- Isotonitazene or N, N-diethyl-2-[[4-(1-methylethoxy) phenyl] methyl]-5-nitro-1H-benzimidazol-1-ethanamine.
- 1B-LSD;
- 1P-ETH-LAD;
- 1P-LSD;
- ALD-52;
- AL-LAD or ALLY-LAD;
- ECPLA;
- EIPLA;
- ETH-LAD;
- LAH or LSH;
- LAMPA;
- LSA;
- LSB;
- LSM-775;
- LSZ;
- MIPLA;
- OML-632;
- PARGY-LAD;
- PRO-LAD.
Sources
1.
1.1.A
- https://www.santepubliquefrance.fr/...s/articles/quelles-sont-les-drogues-illicites
- https://www.ofdt.fr/BDD/publications/docs/DADE2019.pdf
- https://www.legifrance.gouv.fr/loda/id/JORFTEXT000000533085/
- https://www.drogues-info-service.fr/Tout-savoir-sur-les-drogues/Le-dico-des-drogues
- https://www.legifrance.gouv.fr/jorf/id/JORFTEXT000034372039
- https://ansm.sante.fr/actualites/la...x-de-ses-derives-sur-la-liste-des-stupefiants
- https://www.legifrance.gouv.fr/loda/id/JORFTEXT000000533085/
1.1.B
- Personnal findings on Telegram (screenshots at question)
- https://www.drogues-info-service.fr.../La-loi-et-les-drogues/Les-drogues-interdites
- https://ansm.sante.fr/actualites/la...x-de-ses-derives-sur-la-liste-des-stupefiants
- https://www.ofdt.fr/BDD/publications/docs/epfxfbj1.pdf
- https://www.ouest-france.fr/societe...n-france-bcf5b9f8-dd28-11ed-b05e-feb93315b60b
1.3
- https://www.entreprises.gouv.fr/fil...urs-chimiques/brochure-de-sensibilisation.pdf
- https://www.entreprises.gouv.fr/fil...-de-drogues-synthese-de-la-reglementation.pdf
- https://www.entreprises.gouv.fr/fil...chimiques-drogues/Synthese_reglementation.pdf
1.4
- https://www.legifrance.gouv.fr/codes/section_lc/LEGITEXT000006070719/LEGISCTA000006165284/2020-12-16
- https://www.legifrance.gouv.fr/codes/section_lc/LEGITEXT000006070719/LEGISCTA000006165284/
- https://www.santepubliquefrance.fr/...t-la-loi-en-cas-de-consommation-de-stupefiant
- https://www.drogues-info-service.fr...et-les-drogues/La-publicite-faite-aux-drogues
2.
2.1
- Personnal findings on Telegram, Whatsapp, Snapchat (screenshots at question)
- https://similarweb.com/
- Personnal findings on Telegram, Whatsapp, Snapchat (screenshots at question)
- https://www.01net.com/app/uploads/2021/02/drogues-france.jpg
- https://www.radiofrance.fr/francein...s-promos-comme-dans-l-economie-legale-3858056
- https://www.01net.com/actualites/te...e-migre-vers-les-reseaux-sociaux-2031971.html
- https://images.bfmtv.com/x2sNZ0v7VQ...98x708/398x0/images/Capture-decran-193296.jpg
- https://www.medi1news.com/fr/article/312782.html
- https://www.interieur.gouv.fr/sites...02-DP-BILAN-2022-LUTTE-CONTRE-LES-DROGUES.pdf
- https://www.europe1.fr/Police-Justice/plus-de-36400-interpellations-en-lien-avec-le-trafic-de-drogue-en-2023-4226345#:~:text=D'apr%C3%A8s%20les%20chiffres%20communiqu%C3%A9s,(198%20kg%20en%202022).
- https://www.legifrance.gouv.fr/codes/section_lc/LEGITEXT000006070719/LEGISCTA000006165284/
- https://www.francetvinfo.fr/societe...20-lors-de-reglements-de-comptes_4335643.html
- https://ssmsi.shinyapps.io/serieschronologiques/
- https://www.vie-publique.fr/en-bref/288058-insecurite-et-delinquance-les-premiers-chiffres-2022#:~:text=Nombre%20de%20faits%20constat%C3%A9s%20en%202022%20et%20taux%20d'%C3%A9volution&text=Affiche%20actuellement%20lignes%201%20%C3%A0%2014.&text=Lecture%20%3A%20le%20nombre%20de%20victimes,Champ%20%3A%20France
- https://www.lemonde.fr/societe/arti...gue-sur-l-ampleur-du-trafic_6225495_3224.html
2.5
- https://www.ofdt.fr/produits-et-addictions/de-z/cannabis/
- https://www.ofdt.fr/produits-et-addictions/de-z/cocaine/
- https://www.ofdt.fr/produits-et-addictions/de-z/ecstasy-mdma/
- https://www.ofdt.fr/produits-et-addictions/de-z/heroine/
- https://www.ofdt.fr/produits-et-addictions/de-z/poppers/
- https://www.ofdt.fr/produits-et-addictions/de-z/champignons-hallucinogenes/
- https://www.ofdt.fr/produits-et-addictions/de-z/lsd/
- https://www.01net.com/actualites/te...e-migre-vers-les-reseaux-sociaux-2031971.html
- https://fr.statista.com/statistiques/593283/prix-moyen-drogues-france/
- https://fr.wikipedia.org/wiki/Économie_du_trafic_de_drogue_en_France
- https://fr.wikipedia.org/wiki/Drogues_légales#:~:text=Les drogues légales les plus,ici pour en savoir plus.
- https://institutadios.com/drogue-ad...les-sont-les-substances-autorisees-en-france/
- https://www.ouest-france.fr/societe...pefiants-8a80ee0c-31d3-11ee-a90d-d926eb9e6656
- https://www.slate.fr/story/250429/h...e-consommation-trafic-saisies-villes-moyennes
- https://vih.org/drogues-et-rdr/20240122/marseille-capitale-du-futur/
- https://www.interieur.gouv.fr/actua...des-infractions-a-legislation-sur-stupefiants
- https://www.interieur.gouv.fr/Inter...olitiques-de-la-ville-2019-Fiches-thematiques
- https://mobile.interieur.gouv.fr/content/download/130701/1039808/file/IREF_SECUR21-F11.pdf
4.
- Personnal findings on Telegram, Whatsapp, Snapchat (screenshots at question)
- See question for all the links
- https://www.lebigdata.fr/cryptomonnaie-usage-criminel-chainalysis
- Personnal findings on Telegram, Whatsapp, Snapchat (screenshots at question)
- Personnal findings on Telegram, Whatsapp, Snapchat (screenshots at question)
- https://www.cairn.info/revue-vie-sociale-et-traitements-2014-4-page-24.htm
- https://www.santepubliquefrance.fr/presse/2022/les-usages-de-cannabis-en-population-adulte-en-2021#:~:text=Si la consommation de cannabis,ans entre 1992 et 2021.
- https://www.lanouvellerepublique.fr...mateurs-de-cannabis-est-passee-de-25-a-33-ans
- https://www.lemonde.fr/societe/arti...abis-un-profil-vieillissant_6154997_3224.html
- https://www.ofdt.fr/BDD/publications/docs/chap3.pdf
- https://www.cnews.fr/france/2021-11...-nationalite-le-profil-des-mis-en-cause-passe
- https://www.europe1.fr/societe/Portrait-robot-d-un-dealer-295120
- https://www.ouest-france.fr/societe...n-france-15789552-55f9-11ee-aab6-4085e5fd9724
- https://www.ouest-france.fr/societe...pefiants-8a80ee0c-31d3-11ee-a90d-d926eb9e6656
By @Magicshroom et @France
